CA2338021A1 - Odontostomatologic use of apatite-based nanostructured materials - Google Patents
Odontostomatologic use of apatite-based nanostructured materials Download PDFInfo
- Publication number
- CA2338021A1 CA2338021A1 CA002338021A CA2338021A CA2338021A1 CA 2338021 A1 CA2338021 A1 CA 2338021A1 CA 002338021 A CA002338021 A CA 002338021A CA 2338021 A CA2338021 A CA 2338021A CA 2338021 A1 CA2338021 A1 CA 2338021A1
- Authority
- CA
- Canada
- Prior art keywords
- dentine
- apatite
- gel
- use according
- enamel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229910052586 apatite Inorganic materials 0.000 title claims abstract description 51
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 title claims abstract description 49
- 239000002086 nanomaterial Substances 0.000 title claims abstract description 17
- 210000004268 dentin Anatomy 0.000 claims abstract description 73
- 239000000463 material Substances 0.000 claims abstract description 66
- 210000005239 tubule Anatomy 0.000 claims abstract description 40
- 238000011282 treatment Methods 0.000 claims abstract description 36
- 201000002170 dentin sensitivity Diseases 0.000 claims abstract description 27
- 239000000243 solution Substances 0.000 claims abstract description 26
- 210000003298 dental enamel Anatomy 0.000 claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 230000007547 defect Effects 0.000 claims abstract description 6
- 239000004568 cement Substances 0.000 claims abstract description 4
- 239000000606 toothpaste Substances 0.000 claims abstract description 4
- 239000000499 gel Substances 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 20
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 19
- 239000011575 calcium Substances 0.000 claims description 18
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 18
- 238000002560 therapeutic procedure Methods 0.000 claims description 16
- 239000011347 resin Substances 0.000 claims description 13
- 229920005989 resin Polymers 0.000 claims description 13
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 claims description 12
- 235000011006 sodium potassium tartrate Nutrition 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 10
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims description 10
- 239000001639 calcium acetate Substances 0.000 claims description 10
- 235000011092 calcium acetate Nutrition 0.000 claims description 10
- 229960005147 calcium acetate Drugs 0.000 claims description 10
- 150000001768 cations Chemical class 0.000 claims description 10
- 230000009467 reduction Effects 0.000 claims description 10
- 150000001450 anions Chemical group 0.000 claims description 9
- 229940074439 potassium sodium tartrate Drugs 0.000 claims description 7
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 239000006072 paste Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 230000001681 protective effect Effects 0.000 claims description 6
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 5
- 241000282414 Homo sapiens Species 0.000 claims description 5
- 229910001424 calcium ion Inorganic materials 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 4
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 4
- 235000002906 tartaric acid Nutrition 0.000 claims description 4
- 239000011975 tartaric acid Substances 0.000 claims description 4
- 241000282898 Sus scrofa Species 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 239000002324 mouth wash Substances 0.000 claims description 3
- 229910001427 strontium ion Inorganic materials 0.000 claims description 3
- 229940034610 toothpaste Drugs 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- XDFCIPNJCBUZJN-UHFFFAOYSA-N barium(2+) Chemical compound [Ba+2] XDFCIPNJCBUZJN-UHFFFAOYSA-N 0.000 claims description 2
- 210000003074 dental pulp Anatomy 0.000 claims description 2
- 229940051866 mouthwash Drugs 0.000 claims description 2
- 239000000565 sealant Substances 0.000 claims description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 6
- 229920001223 polyethylene glycol Polymers 0.000 claims 5
- 239000002202 Polyethylene glycol Substances 0.000 claims 4
- 229940045110 chitosan Drugs 0.000 claims 3
- 241000283690 Bos taurus Species 0.000 claims 2
- 229920001661 Chitosan Polymers 0.000 claims 2
- 241000700159 Rattus Species 0.000 claims 2
- 230000001476 alcoholic effect Effects 0.000 claims 2
- 229960004494 calcium gluconate Drugs 0.000 claims 2
- 239000004227 calcium gluconate Substances 0.000 claims 2
- 235000013927 calcium gluconate Nutrition 0.000 claims 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 210000002435 tendon Anatomy 0.000 claims 2
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 claims 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims 1
- 229920002125 Sokalan® Polymers 0.000 claims 1
- FLASNYPZGWUPSU-SICDJOISSA-N chitosan Chemical class O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H](O[C@@H](O[C@@H]2[C@H](O[C@@H](O)[C@H](N)[C@H]2O)CO)[C@H](N)[C@H]1O)CO)NC(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1N FLASNYPZGWUPSU-SICDJOISSA-N 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 claims 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 claims 1
- 239000004005 microsphere Substances 0.000 claims 1
- 239000004584 polyacrylic acid Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 12
- 239000002707 nanocrystalline material Substances 0.000 abstract description 6
- 230000002950 deficient Effects 0.000 abstract description 4
- 230000009257 reactivity Effects 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 2
- JLQUFIHWVLZVTJ-UHFFFAOYSA-N carbosulfan Chemical compound CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 JLQUFIHWVLZVTJ-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 description 35
- 239000002253 acid Substances 0.000 description 21
- 230000015572 biosynthetic process Effects 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 17
- 239000000047 product Substances 0.000 description 15
- 229910019142 PO4 Inorganic materials 0.000 description 13
- 150000002500 ions Chemical class 0.000 description 13
- 230000035699 permeability Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 235000021317 phosphate Nutrition 0.000 description 12
- 208000002599 Smear Layer Diseases 0.000 description 11
- 210000000988 bone and bone Anatomy 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 11
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 10
- 206010020751 Hypersensitivity Diseases 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 238000005755 formation reaction Methods 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 208000026935 allergic disease Diseases 0.000 description 8
- 239000001506 calcium phosphate Substances 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 230000009610 hypersensitivity Effects 0.000 description 8
- 230000003239 periodontal effect Effects 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 235000001465 calcium Nutrition 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 229960005069 calcium Drugs 0.000 description 7
- 238000009833 condensation Methods 0.000 description 7
- 230000005494 condensation Effects 0.000 description 7
- 239000000551 dentifrice Substances 0.000 description 7
- 239000010452 phosphate Substances 0.000 description 7
- 239000002243 precursor Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 6
- 235000011010 calcium phosphates Nutrition 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- -1 Sr2+ ion Chemical class 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 229910000389 calcium phosphate Inorganic materials 0.000 description 4
- 229960005188 collagen Drugs 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000000151 deposition Methods 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 4
- 238000005470 impregnation Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 235000001055 magnesium Nutrition 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 229940091250 magnesium supplement Drugs 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000013081 microcrystal Substances 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229960003975 potassium Drugs 0.000 description 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- 238000002441 X-ray diffraction Methods 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000010534 mechanism of action Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229940085991 phosphate ion Drugs 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000006104 solid solution Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HECLRDQVFMWTQS-UHFFFAOYSA-N Dicyclopentadiene Chemical compound C1C2C3CC=CC3C1C=C2 HECLRDQVFMWTQS-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920005372 Plexiglas® Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 2
- 239000001354 calcium citrate Substances 0.000 description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 description 2
- 238000009388 chemical precipitation Methods 0.000 description 2
- 238000004581 coalescence Methods 0.000 description 2
- 238000007596 consolidation process Methods 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229910052587 fluorapatite Inorganic materials 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 150000003891 oxalate salts Chemical class 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 239000001508 potassium citrate Substances 0.000 description 2
- 229960002635 potassium citrate Drugs 0.000 description 2
- 235000011082 potassium citrates Nutrition 0.000 description 2
- 239000004323 potassium nitrate Substances 0.000 description 2
- 235000010333 potassium nitrate Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 2
- 229960002799 stannous fluoride Drugs 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 229940047908 strontium chloride hexahydrate Drugs 0.000 description 2
- AMGRXJSJSONEEG-UHFFFAOYSA-L strontium dichloride hexahydrate Chemical compound O.O.O.O.O.O.Cl[Sr]Cl AMGRXJSJSONEEG-UHFFFAOYSA-L 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 229940095064 tartrate Drugs 0.000 description 2
- 235000013337 tricalcium citrate Nutrition 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZUXNHFFVQWADJL-UHFFFAOYSA-N 3,4,5-trimethoxy-n-(2-methoxyethyl)-n-(4-phenyl-1,3-thiazol-2-yl)benzamide Chemical compound N=1C(C=2C=CC=CC=2)=CSC=1N(CCOC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 ZUXNHFFVQWADJL-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000004434 Calcinosis Diseases 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 241000072692 Erica <spider> Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 241000845077 Iare Species 0.000 description 1
- 229910019092 Mg-O Inorganic materials 0.000 description 1
- 229910019395 Mg—O Inorganic materials 0.000 description 1
- 101100400378 Mus musculus Marveld2 gene Proteins 0.000 description 1
- 201000004328 Pulpitis Diseases 0.000 description 1
- 206010037464 Pulpitis dental Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010044029 Tooth deposit Diseases 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000004840 adhesive resin Substances 0.000 description 1
- 229920006223 adhesive resin Polymers 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000010210 aluminium Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- 229940095626 calcium fluoride Drugs 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- DRTSMJJTVBYBPG-UHFFFAOYSA-L calcium;carbonic acid;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [Ca+2].[O-]C([O-])=O.OP(O)(F)=O DRTSMJJTVBYBPG-UHFFFAOYSA-L 0.000 description 1
- KBQXDPRNSDVNLB-UHFFFAOYSA-L calcium;carbonic acid;hydrogen phosphate Chemical compound [Ca+2].OC(O)=O.OP([O-])([O-])=O KBQXDPRNSDVNLB-UHFFFAOYSA-L 0.000 description 1
- GFIKIVSYJDVOOZ-UHFFFAOYSA-L calcium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [Ca+2].[O-]P([O-])(F)=O GFIKIVSYJDVOOZ-UHFFFAOYSA-L 0.000 description 1
- 230000000248 cariostatic effect Effects 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 235000017168 chlorine Nutrition 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940060038 chlorine Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000004695 complexes Chemical class 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 239000003975 dentin desensitizing agent Substances 0.000 description 1
- 210000002531 dentinal fluid Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229940091249 fluoride supplement Drugs 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000003178 glass ionomer cement Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000002488 metal-organic chemical vapour deposition Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000001451 molecular beam epitaxy Methods 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000004416 odontoblast Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- HTYIXCKSEQQCJO-UHFFFAOYSA-N phenaglycodol Chemical compound CC(C)(O)C(C)(O)C1=CC=C(Cl)C=C1 HTYIXCKSEQQCJO-UHFFFAOYSA-N 0.000 description 1
- 238000000016 photochemical curing Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 229940093928 potassium nitrate Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000013102 re-test Methods 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 230000002226 simultaneous effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002311 subsequent effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical group COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 239000011882 ultra-fine particle Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/15—Compositions characterised by their physical properties
- A61K6/17—Particle size
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/20—Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
- A61K6/52—Cleaning; Disinfecting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
- A61K6/54—Filling; Sealing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/70—Preparations for dentistry comprising inorganic additives
- A61K6/71—Fillers
- A61K6/74—Fillers comprising phosphorus-containing compounds
- A61K6/75—Apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/849—Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Landscapes
- Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
- Cosmetics (AREA)
Abstract
Biocompatible nanocrystalline materials based on apatite with high specific surface properties, having average size of the crystallites comprised betwee n 0.5 and 200 nm and possible lattice deformations and/or defects, are propose d for use in the fields of dentistry and dental hygiene, in particular for the production of preparations, solutions, toothpastes and materials for the remineralisation of enamel and dentine and for the treatment of dentine hypersensitivity. The apatite-based nanostructured materials appear to posse ss specific physico-chemical properties connected to their nanocrystalline and defective nature, such as the remarkable surface chemical reactivity and the hygroscopicity, which allow the material to recrystallise as a result of the metastable character of the nanocrystalline system, to be used for the remineralisation of enamel and dentine. In addition, they possess the most suitable grain sizes to easily and deeply penetrate mechanically within the dentinal tubules, and also cause it to cement the internal surface thereof, both by swelling and by readily reacting with the natural tissues.
Description
I~'.
~cv.v. rWV:I:YA-ML~E.IVC.'H~~) t~ :.~w.~_i0= 0 : 7:39 : OGOOUOUOOU-~ -~-4J 89 2~994465:~k 8 ' ~ ; : r~. t~:.. : 0aa~caa 0i ~~,. 2am ~~: ~7 ~a Qt3~11'~TC~ST~3iV#ihTt~LOC~tC USE fli= APATITE~.BASiED
NA~IQSTRt~G"tt.iREO ~iTER', SPEC#F1CAT#tJhl The present invention concerns sdm~P odontostorrsato#agic uses of apatite-based nanc~structured material. Il~iare spe~cifirall~r, the invention con-cerns the application c~f biocornpatible crystalline products based on apatite with high specific surface properties, #~aving sing#e oanstituent crystals ~afi ~a nartometric size, in the treatment of dentine hypersensitivity and in the remin.-eraiisatian of denta# tissue_ As it is known, dentine sensitivity ar hypersensitivity is a complex s~mptomato(ogy, ci ~aract~ised by pain and s~,nsitiv"ety to therma#, mechanica#
(i.e. taco#ea, cherrrica# and osmotic $timuii caused by exposure of the dentin ~
~5 the oral environrnentr Several data on the ~p#derniology of dentine hypersen-sitivity have been pubiisheGl in the #atest y~ar:~, r$vealing, inter alto, that such ~c3inica! condition afiFects more than 9 5°~b of the population in the age range between 20 and 4~ years, with a particular preFerence for females.
C3entine hypersensitivity may be primary, i.e: not resulting Pram any 24 therapeutic intervention on the ~dents# components, or it may be secnndary to t previous periodontal interventions andlor to injuries resulting it dentine expo-sure, or to restorations {inc#uding dental pro~~theses) vvitft projecting margins or having an i~acorrect shape. After an exfens#ve periodontal intervention, espeoiaiiy of resa~ctive surgery, Patients quite; frequently report a hy~ersensi-a~ tivity naf previ~s#y present !n such cases the affection is also referred to as radicular tar cervica# hypersensitivity.
Accord#ng to the therrry advanced by ~r~nnstrorn {i,e., the hydrody-namic theory of pain induction; see l~I. 8ra~nnstrs~m, A. AstrQm: The hydrody-r~mic~ of the der~ian: its possib#e retationshi~p to dentina# pain. tni. Dent.
.1., 3c 22:29-227 {19T2)) and. cater, by P sh#ey (~.H. Pashley, N#echanisms of deritin sensitivity. fler~t C:in. ~#orfh Am:; 34= 443-473 (1990)y, the presence of ~'..'~#~D ~i _2-exposed dentine and of open dentinal tubules ;allows the dentine fluid to move within the said tubules. Such displacement is induced by mechanical stimuli (such as, for instance, by passing the specill~um over the tooth surface), by osmotic and chemical stimuli (such as by the. contact with food, beverages, etc.) and by thermal stimuli (bath hot and, specially, cold). However, it has not been ascertained, so far, whether the displacement of the dentine fluid causes a nervous stimulation (for instance, a stimulation of intratubular nerve fibres) or whether it directly stimulates the odontoblasts projections (which occupy about 2/3 of the whole tubule length).
In .all cases, the greater is the expo;>ed dentine surface (with non-obstructed tubules), the greater is the likelihood that the patient be sensitive to any stimuli. In other terms, the exposed dentinE; behaves as a semi-permeable membrane, wherein the dentine tubules represent the membrane pores.
Therefore, the diameter and number of the exposed tubules largely affect the ~s degree of sensitivity, as it has been ascertained in vivo by Yoshiyama et al.
(M. Yoshiyama, Y. Noiri, K. Oaki, A. Uchida, Y.. Ishikawa, H. Ishida, Transmis-sion electron microscopic character9sation of hypersensitive human radicufar dentiri, J. Dent. Res.; 69: 1293-1297 {1990)).
As a direct clinical consequence of the foregoing, any dental treatment 2o involving the removal of enamel and dentine, and thus the opening of the dental tubules, unavoidably results in an increased sensitivity. Accordingly, the patient with dentine hypersensitivity is found to have, at the same time, an area of exposed dentine (i.e., an area deprived of enamel andlor of gum cov-eying) with open tubular orifices, and no kind of surface debris or smear layer 25 (the latter term actually meaning the layer of debris that normally covers the dentine and closes the tubules with plugs, i.e. the so-called smear plugs) obstructing, at least partially, the dentine tubulEa.
Food may play a primary role in causing the onset or, more properly, the becoming acute again, of dentine hypersensitivity. As a matter of fact, so several food items or beverages have acid properties, as they contain citric, phosphoric or malefic acid, and they may easily effect the chemical removal of the surface smear layer, thus opening the df:ntine tubules. Also other food items or beverages, such as red wine, citrus fruits and unr#pe fruits in general, have been reported to have effects on the denitine hypersensitivity. In addition, as pointed out before, a particular situation may occur in patients who have undergone a resective periodontal intervention, about 80% of whom reports dentine sensitivity after the periodontal therapy. Also other periodontal proce-dures may be related to the occurrence of dentine hypersensitivity: for in-stance, during the operative procedures of dental calculus removal, root scalling, root planning, root polishing and surFace cleaning, any residual ce-ment (which is often already absent) and any infected dentine are removed, ~o thus resulting in the removal of large root surfiaces and in the exposure of an extremely high number of open dentine tubules. In the event that such expo-sure allows the passage of intratubular fluid from the interior of the pulp cavity to the exterior thereof, with loss of plasma proteins and electrolytes, and, vice-versa, the passage of liquid and toxins from tile exterior of the pulp cavity to ~s the interior thereof, a temporary pulpitis occurs, accompanied by a painful symptomatology. The latter is normafly felt aftf;r some hours or days from the intervention. Very often, the symptoms spontaneously decrease owing to the spontaneous obstruction of the tubules, resulting from the deposition of bacte-rial debris, the precipitation of proteins and fibrinogen and the production of a 20 smear layer by the patient himself during the normal dental hygiene prose=
dures with the toothbrush (Pashley, 1990, ioc. ~;it.).
Since the presence of open dentine tubules represents the critical stage of dentine hypersensitivity, the most reliable therapy aims, basically, at occluding the said tubules. A different therape~~utic approach, aiming at reduc-25 ing the receptor sensitivity, consists in increa;>ing the intratubular concentra-tion of potassium and strontium ions (by means of the application of dentifrice or other agents), in order to make the dentinal nerve fibres less excitable.
However, the hypothesis of an activity of the IK* and Sr2* ions in influencing the nerve stimulus conduction has found limited clinical confirmation (D.G.
3o Gillam, J.S. Bulman, R.J. Jackson, H.H. Newman, Efficacy of a potassium nitrate mouthwash in alleviating cervical dentine sensitivity (CDS), J. Clin.
Pertodontol. 23: 993-99? ( 1996)).
~cv.v. rWV:I:YA-ML~E.IVC.'H~~) t~ :.~w.~_i0= 0 : 7:39 : OGOOUOUOOU-~ -~-4J 89 2~994465:~k 8 ' ~ ; : r~. t~:.. : 0aa~caa 0i ~~,. 2am ~~: ~7 ~a Qt3~11'~TC~ST~3iV#ihTt~LOC~tC USE fli= APATITE~.BASiED
NA~IQSTRt~G"tt.iREO ~iTER', SPEC#F1CAT#tJhl The present invention concerns sdm~P odontostorrsato#agic uses of apatite-based nanc~structured material. Il~iare spe~cifirall~r, the invention con-cerns the application c~f biocornpatible crystalline products based on apatite with high specific surface properties, #~aving sing#e oanstituent crystals ~afi ~a nartometric size, in the treatment of dentine hypersensitivity and in the remin.-eraiisatian of denta# tissue_ As it is known, dentine sensitivity ar hypersensitivity is a complex s~mptomato(ogy, ci ~aract~ised by pain and s~,nsitiv"ety to therma#, mechanica#
(i.e. taco#ea, cherrrica# and osmotic $timuii caused by exposure of the dentin ~
~5 the oral environrnentr Several data on the ~p#derniology of dentine hypersen-sitivity have been pubiisheGl in the #atest y~ar:~, r$vealing, inter alto, that such ~c3inica! condition afiFects more than 9 5°~b of the population in the age range between 20 and 4~ years, with a particular preFerence for females.
C3entine hypersensitivity may be primary, i.e: not resulting Pram any 24 therapeutic intervention on the ~dents# components, or it may be secnndary to t previous periodontal interventions andlor to injuries resulting it dentine expo-sure, or to restorations {inc#uding dental pro~~theses) vvitft projecting margins or having an i~acorrect shape. After an exfens#ve periodontal intervention, espeoiaiiy of resa~ctive surgery, Patients quite; frequently report a hy~ersensi-a~ tivity naf previ~s#y present !n such cases the affection is also referred to as radicular tar cervica# hypersensitivity.
Accord#ng to the therrry advanced by ~r~nnstrorn {i,e., the hydrody-namic theory of pain induction; see l~I. 8ra~nnstrs~m, A. AstrQm: The hydrody-r~mic~ of the der~ian: its possib#e retationshi~p to dentina# pain. tni. Dent.
.1., 3c 22:29-227 {19T2)) and. cater, by P sh#ey (~.H. Pashley, N#echanisms of deritin sensitivity. fler~t C:in. ~#orfh Am:; 34= 443-473 (1990)y, the presence of ~'..'~#~D ~i _2-exposed dentine and of open dentinal tubules ;allows the dentine fluid to move within the said tubules. Such displacement is induced by mechanical stimuli (such as, for instance, by passing the specill~um over the tooth surface), by osmotic and chemical stimuli (such as by the. contact with food, beverages, etc.) and by thermal stimuli (bath hot and, specially, cold). However, it has not been ascertained, so far, whether the displacement of the dentine fluid causes a nervous stimulation (for instance, a stimulation of intratubular nerve fibres) or whether it directly stimulates the odontoblasts projections (which occupy about 2/3 of the whole tubule length).
In .all cases, the greater is the expo;>ed dentine surface (with non-obstructed tubules), the greater is the likelihood that the patient be sensitive to any stimuli. In other terms, the exposed dentinE; behaves as a semi-permeable membrane, wherein the dentine tubules represent the membrane pores.
Therefore, the diameter and number of the exposed tubules largely affect the ~s degree of sensitivity, as it has been ascertained in vivo by Yoshiyama et al.
(M. Yoshiyama, Y. Noiri, K. Oaki, A. Uchida, Y.. Ishikawa, H. Ishida, Transmis-sion electron microscopic character9sation of hypersensitive human radicufar dentiri, J. Dent. Res.; 69: 1293-1297 {1990)).
As a direct clinical consequence of the foregoing, any dental treatment 2o involving the removal of enamel and dentine, and thus the opening of the dental tubules, unavoidably results in an increased sensitivity. Accordingly, the patient with dentine hypersensitivity is found to have, at the same time, an area of exposed dentine (i.e., an area deprived of enamel andlor of gum cov-eying) with open tubular orifices, and no kind of surface debris or smear layer 25 (the latter term actually meaning the layer of debris that normally covers the dentine and closes the tubules with plugs, i.e. the so-called smear plugs) obstructing, at least partially, the dentine tubulEa.
Food may play a primary role in causing the onset or, more properly, the becoming acute again, of dentine hypersensitivity. As a matter of fact, so several food items or beverages have acid properties, as they contain citric, phosphoric or malefic acid, and they may easily effect the chemical removal of the surface smear layer, thus opening the df:ntine tubules. Also other food items or beverages, such as red wine, citrus fruits and unr#pe fruits in general, have been reported to have effects on the denitine hypersensitivity. In addition, as pointed out before, a particular situation may occur in patients who have undergone a resective periodontal intervention, about 80% of whom reports dentine sensitivity after the periodontal therapy. Also other periodontal proce-dures may be related to the occurrence of dentine hypersensitivity: for in-stance, during the operative procedures of dental calculus removal, root scalling, root planning, root polishing and surFace cleaning, any residual ce-ment (which is often already absent) and any infected dentine are removed, ~o thus resulting in the removal of large root surfiaces and in the exposure of an extremely high number of open dentine tubules. In the event that such expo-sure allows the passage of intratubular fluid from the interior of the pulp cavity to the exterior thereof, with loss of plasma proteins and electrolytes, and, vice-versa, the passage of liquid and toxins from tile exterior of the pulp cavity to ~s the interior thereof, a temporary pulpitis occurs, accompanied by a painful symptomatology. The latter is normafly felt aftf;r some hours or days from the intervention. Very often, the symptoms spontaneously decrease owing to the spontaneous obstruction of the tubules, resulting from the deposition of bacte-rial debris, the precipitation of proteins and fibrinogen and the production of a 20 smear layer by the patient himself during the normal dental hygiene prose=
dures with the toothbrush (Pashley, 1990, ioc. ~;it.).
Since the presence of open dentine tubules represents the critical stage of dentine hypersensitivity, the most reliable therapy aims, basically, at occluding the said tubules. A different therape~~utic approach, aiming at reduc-25 ing the receptor sensitivity, consists in increa;>ing the intratubular concentra-tion of potassium and strontium ions (by means of the application of dentifrice or other agents), in order to make the dentinal nerve fibres less excitable.
However, the hypothesis of an activity of the IK* and Sr2* ions in influencing the nerve stimulus conduction has found limited clinical confirmation (D.G.
3o Gillam, J.S. Bulman, R.J. Jackson, H.H. Newman, Efficacy of a potassium nitrate mouthwash in alleviating cervical dentine sensitivity (CDS), J. Clin.
Pertodontol. 23: 993-99? ( 1996)).
As far as home-therapy is concerned, several dentifrices and gels specific for sensitive teeth are commercially available, containing, for instance, strontium chloride hexahydrate, potassium nitrate or citrate or stannous fluo-ride, and also some mouthwashes and periodontal gels have been proposed.
s Data reported in the literature show that several toothpaste products possess some desensitising action, which is often independent of the kind of active ingredient employed (D.G. Gillam, J.S. Buiman, R.J. Jackson, H.N. Newman, Comparison of 2 desensitizing dentifrices with a commercially available fluo-ride dentifrice in alleviating cervical dentine sensitivity, J. Periodontol., 67:
~0 737-742, {1996)). Very often, also the other components of the toothpaste play an important role, in that they are able themselves to seal the dentine tubules. In addition, the placebo effect plays a role considered by someone to be a primary one.
The most studied and well-known products for home therapy include 15 dentifrices containing strontium chloride hexahydrate. The latter, as pointed out in the foregoing, is used in view of its ability of closing the dentine tubules, rather than for its activity in depressing the den~tinal nerve fibres stimulation. It is believed that the Sr2+ ion reacts with the ap<~tite matrix of the dentine, thus forming with said matrix an insoluble strontium-apatite. The latter settles as a 20 layer of microcrystals, that are able to reduce the functional diameter of the dentine tubules. Also stannous fluoride is believed to act by forming insoluble complexes with- dentine {i.e. fluoroapatite or calcium--fluoride), which com-plexes are able to obstruct the tubular lumen. As tar as potassium citrate is concerned, it has been shown that the citrate ion chelates the calcium con-es tained in the tooth hydroxyapatite, thus resulting in the formation of a soluble calcium citrate {Misra D.N., Interaction of citrate Acid with Hydroxyapatite:
Surface exchange of ions and precipitate of calcium citrate, J. Dent. Res., 75(6), 1418-1425, June 1996).
In this connection, other dentifrices and desensitising preparations 3o have been proposed, which, rather than being based on products that form insoluble precipitates by reacting in the oral environment, are based on the direct use of apatite, i.e., the basic material making up the dentine, in the microcrystalline state. For instance, the US patent No. 4634589 (Wurttember-gische Parfumerie-Fabrik} discloses the use oaf a crystalline apatite having a particle size of less than 8 pm as an abrasive; and polishing agent, active in the treatment of dentine hypersensitivity and also having a remineralising s action on the dental tissue. The dentifrice formulation proposed contains at least 15% by weight of such ingredient. Similarly, the European patent appli-cation No. 0346957 (Unilever) discloses the use of hydroxyapatite as a de-sensitising abrasive agent for dental products. In this case, the hydroxyapatite particle size is 1-15 Nm, and the formulation proposed also comprises a source of potassium andlor strontium {as a further desensitising agent).
The treatment of dentine hypersensitivity by home therapy, however, has the drawback of requiring long periods of time (often more than four weeks) to reach any appreciable clinical results. fn addition, the said results are often only partial, as a great amount of co~-operation is required from the 15 patient. In view of that, the treatment of dentine hypersensitivity is preferably carried out at the dentist's consulting room, by directly treating the affected tooth (or teeth}. Also in this case, the main aim is to occlude the open dentine tubules. Several techniques and materials have been proposed to that aim, according to the degree of seriousness of the symptoms. Such techniques can 20 be schematically divided into four main groups: 1 ) mechanical treatment of the sensitive surface in order to obtain a new smear layer; 2) application of agents effective in occluding the dentinal tubules, either directly or by forming insolu-ble precipitates; 3} impregnation and obstruction of the dentine tubules by means of adhesives; 4} application of dental restoration materials, optionally 2s together with intraoral devices for sustained release of fluorine. In the most serious cases, as well as in those cases where any other kind of therapy is ineffective, the dental restoration and the endodontal treatment are often in-eluded in order to finally solve the problem.
As regards the first one of the treatnnents mentioned above, since 3o dentine is not permeable when a suitable smear layer is present, it is often possible; by simply applying an abrasive paste (such as the Nupro paste} and by working the dentine surface by means of silicone or rubber cups, to obtain a thin and uniform smear layer and, consequ~:ntly, the obstruction of the tu-bules. Although simple, such treatment does not give long-lasting results, as the smear layer is soluble (specially in an acidl environment), and therefore it may be easily removed by the patient. An incorrect brushing of the teeth or the ingestion of acid liquids (such as fruit juices, beverages, etc.) are often suffi-cient to cause the smear layer removal. Therefore, the adoption ofi the above treatment is limited to non serious cases, e.g. to treat patients after a perio-dontal intervention with exposure of limited deintine surfaces and without any previous history of dentine hypersensitivity.
~o The second kind of medical treatment mentioned in the foregoing consists, for instance, in applying oxalates (such as potassium, iron or alu-minium oxalate, and oxalic acid) on the affected dentine surface. Such agents may react with the dentinal apatite constituents, thus forming insoluble cal-cium oxalate microcrystals on the surface and in the interior of the dentine ~s tubules. The solutions containing the concerned agent may easily be applied on the dentine surface by means of little brushes, and they may be left in situ for 2-3 minutes, this period of time being enough for the said microcrystals to form. It is to be noted, however, that this technique may involve some prob-lems due to the toxicity of oxalates. Also silver nitrate, another agent em-2o ployed for a long time for the same purpose, has a mechanism of action based on the formation of precipitates (Ag chloride) which occlude the dentine tubutes. _ ..
The same kind of therapeutic approach also includes the direct appli-cation of microcrystalline apatite, as mentioned in the foregoing in connection 25 with products for home therapy. More specifically, the medical treatment in-cludes the use of an ultramicronised apatite, ouch as that disclosed, for in-stance, in the Italian patent No. 1271874, where: the particle size of about 70%
of the apatite microcrystals is less than '! pm (0.2-1 Irm}. Such product is con-sidered to be more active than the micronisedl apatite products disclosed in 3o the foregoing, on the basis of the simple consideration that the dentine tubules have an average diameter of about 1.3-3.5 um. Therefore, crystals having slightly submicronic size may, theoretically, pE;netrate within the dentine tu-WO 00/03747 PCTIIT99l00224 bules, thus performing a better mechanical occlusion. On the contrary, the micron-sized crystals disclosed in the two previously cited patent documents may only create an occlusive layer on the dentine surface, without penetrating into the tubules.
s Considering the medical treatments, however, the procedures be-longing to the third group referred to above, consisting in dentine impregnation by means of adhesive resins, are considered to be more effective. The resin impregnation technique, proposed by Nordenvall and Brannstrom (K.J. Nor-denvall, M. Brannstrom, In vivo resin imprecanation of dentinal tubules, J.
~o Prosthet. Dent.; 44:630-637 (1980)), has become extremely reliable only after the introduction of dentinal adhesive systems consisting of highly hydrophilic resins, which are able to infiltrate through the dentine and to penetrate within the tubules for some tens of microns. tt has been shown that the dentine sur-face, treated with etching acid (for instance, with phosphoric or malic acid) ~s becomes demineralised up to 4-10 Nm of depth, and rich in partially collapsed collagen fibres only. This treatment enhances the penetration of the resin (usually, a primer) within the dentine tubules and within the collapsed colla-gen. The resin, by penetrating into the tubule;>, forms long plugs (referred to as resin tags) which occlude the tubular lumen and reduce the dentine per-2o meability: In addition, the resin impregnates .and occludes the small lateral channels as well (as it has recently been confirmed by some studies by scan-ping electron microscopy); thus contributing to the formation of a thick resin network effective in stably blocking any movernent of the dentine fluid. A by brid layer made of resin and collagen is thus formed. From the point of view of 2s the mechanism of action, it is not clear whetlher other factors co-operate in reducing the sensitivity, in addition to the tubules occlusion and the conse-quent permeability reduction (which is, very Ilikely, the main mechanism of action). It has been hypothesised that some of the components of the dentinal primers also have a pharmacological action such as to reduce the symptoms.
3o At the present state of knowledge, they impregnation treatment of the exposed dentinal surface with resin is to be considered specific for patients wherein few dental elements show a medium or serious dentine hypersensi-_g-tiVity.
Finally, in the occurrence of widespread and serious dentine hyper-sensitivity, a distinction has to be made between lesions with deficiency of periodontal tissue, wherein surgery represents the treatment of choice, and lesions with extensive enamel loss, wherein a conservative dental restoration is indicated. For the latter purpose, the same dentinal adhesive systems of the previously disclosed method may be used, followed, obviously, by the appli-cation of a composite resin-restorative material; in the alternative, photocuring glass-ionomer cements may be used. This kind of intervention, as pointed out before, is reserved to cases showing a marked deficiency of tissues, or when the hypersensitivity is extremely serious. The further therapeutic step is, obvi-ously, the endodontic treatment of the affected tooth.
In addition to the well established treatments referred to in the fore-going, further literature, mainly patent publications, proposes (besides the ~5 micronised and ultramicronised apatite materials mentioned above) the use of amorphous calcium phosphates, both in order to remineralise (and, optionally, to fluoridate) the dental tissue, and in order to reduce the dentine hypersensi-tivity. The US patent No. 5268167 {American Dental Association Health Foun-dation) proposes, to such aim, the use of amorphous calcium phosphates (i.e., 2o ACP or amorphous calcium phosphate; ACPIF or amorphous calcium fluoro-phosphate; ACCP or amorphous calcium carbonate phosphate). According to the disclosure; the said amorphous salts, or solutions that may originate such salts by precipitation, are applied on the dental tissue surface, and settle thereon and within the same tissue. The amorphous salts are then converted 25 to crystalline apatite, thus performing a remineralising action and reducing dentine sensitivity. In the same frame, the PCT patent application No. WO
94/04460 (American Dental Association Healtlh Foundation) also presents the ACCPF phosphate (i.e., amorphous calcium carbonate fluorophosphate), as a new compound particularly interesting for the same purpose.
3o In the light of the prior art referred to above, it is an object of the pres-ent invention to provide a biocompatible product substantially based on apa-tite, able to satisfactorily comply with various therapeutic requirements in the ,:.....~n~-rrn-nn:~vLt~:v u9- :Za-10--0 : 7::39 : OOU0000000> -t-5~;~ 8:3 :2:3f~:# 9 I~. TEL : ~0~00IO~F30 fli Gen. 20~i 67: 48 r 9 field of dental cage and, frstiy, to effectively and Lastingly counteract dQrr#ine hypersensitivity, by deeply occhding and cemE:nting the derctina tubules, and by exerting a desensitising action that withstands the attack of any chemically aggressive agent presertt in the bras environment, such as acid t~evareges and food.
tn a4cordance with the invention, it has been found that the apatite materials characterised by a nat~a~ysta111ne, preferably defective structure {as opposed to the lcncv~m amorphous and sr~ierocrystaitine Structures, including the uitrarnlcronised forms) lend themselves m~c~ch better to the objects men-30 tinned above, as they allow to achieve remarikable therapeutic results, up to the complete suppression of det~ine hypersensitivity and, in addition, with a considerable ren~ineralisa~on of the denfai (issue. Such results are made possible by the unir~ue features of the cryst;~lline nanostructures, that sub-stantiate the great potential of these advanced materials in many applicative ~5 fields.
In general, ate naraocrystaaiine materials ere artificially synthesised rnaterials, cha~ractertsecD by a constituent phase, of by granular structures, modulated bn a Length scale normally smaller' than 10Q rim. According to the number of dirnensions in which they show a nanametric s~uc~ure, the nano ~c crystalline materials are considered to be with dimensionality eguai to zero t' (clusters of atoms - for instance, dispersed inn a non-nanocrystaliine matrix , fiiarrtents ar tubules), ~Nith dimensicnaiity on~i (multilayers, i.e., layers which are nanornetric in t1-~e only direction of tt~e tt~tiacitnessj, with dimensionallty two tgranular s~uperposltions, ultrafine, or buried layers), or with dimensionafity three ~nanophasic materials, wherein all of the ronstituerrt phases are of nanometric proportions on three dirnensions',t (R.111~, Siegel, in Ma~teriais Sci-enc~ and Technology, Voi. 'I5: Processing oil Metals and Alloys, R_li'V_ Calm, 583 (199~i ~). '1~he particular facnperties c~f the nana~crys#atline materials in com-parison with the conven~i~nai materials res~rEt from the cambirration of their 3o three basic and distinctive features, namely: ij atomic domains (i.e., clusters, grains, I$yers or phases) limited in space to less than ~i00 rim; ii) s#gn~cant atornic fractir~ns asscxiated writh irrter~ace erw~iranmer~ts (that is, grain bounda-'~~g ~~T
ries, interfaces and heterophase; and free surfaces); and iii) interactions among their constituent domains.
At present, it is possible to produce inexpensively, by means of sev-eral physical and chemical processes, clusters of atoms in the range of the nanometric dimensions, containing from -hundreds to tens of thousands of atoms, in such a number as to be assemblablle into materials which advanta-geously incorporate into one single material a multiplicity of effects due to the dimension. The said effects range from the electronic effects of quantum di-mension caused by the spatial confinement of the valence electrons, to the suppression of mechanisms of lattice defects, such as the dislocation genera-tion and the migration towards limited granular dimensions. The basis of the particular pertormances of the nanostructured materials is to be found in the fact that a physical property of matter becomes altered when the entity or the mechanism responsible for such property (or the combination thereof) are confined within a space (defined by the dimension of the atoms set) smaller than a given critical length associated with such entity or mechanism. There-fore, for instance, a metal that is conventionally ductile owing to the usual ease in creating and displacing dislocations through the crystal lattice thereof wil! become remarkably harder when the grain size is reduced down to a criti-2o cal point wherein the dislocation sources are r~o more able to work at the low levels of the applied stress.
in addition to being characterised by t:he dimensions- of-their-ultrafine domain (i.e. grains or layers), the nanocrystalline materials are also charac-terised by the high number of interfaces they contain. Since the number of interfaces present in the nanocrystalline materials is much higher than in the conventional materials, a suitable control, in t;he course of the synthesis;
on the nature of the interfaces created between the constituent phases leads to a control on the nature of the interactions through the said interfaces. In order to have an idea of the importance of the interface environment in a nanocrystal-line material it is sufficient to consider; for instance, that in a material with an average grain size of 5-10 nm the percentage ~of atoms comprised in the grain boundaries is in the range from 15 to 50%.
...... .w~a.a n-mc.~W .tiClY V~ :l:L-lll- V : 'I~~1) : VVV~1VVVVVV-~ ~~ tS~
~4:3JJ't~t~:~flV
h1. Tt'~'-.~ : 000~000000 (31 G~t't: r~~01. 07: d8 P26 In view of the general features of they nanocrystaliine materials re-ferred to in .the faregain~, for the use prop~osec~ according to the invention the apatite-based nanostructured rr~ateriais appe~~r to possess, firstly, the most suitable gt.anufa~r dimensions to easily and deeply penetrate within the dentine ~ tubules which, as pointed out before, have disameters in the range of 1.3-3.~
Nm). In addition, as pointed out before, the concerned materials show specific physiemiaal properfies connected with #h~eir nanocrystatiine nature, such as the re~arkatxle sur~ac~ lira! reactivity and the hygrnscapiaty, which not t~niy allow the material to penetrate mechanically within the tubules, but to also cause it to cement the internal surfaces thereof, both bar swelling and by readily reacting with the natural tissue, and recrystaliising as a result of the rnetastabie character of the nanocrystalline system. Actually, the tatter may have, in this spec~~fic case, a high defective content Apafite-based materials characterisecl by a nanoaystaHine structure appear to have somehow been descrJbed in the PCT patent application No.
9IV0 9711725 ~Etex Gor~r. ), concerning the to~v temperature synthesis of a law crystaJtinity apattte for use in bone tissue gram, Actually, the definition of claw crystailinEty material" given in such text gene~ricatly includes bath amorphous materials and nanocrystatiine materials (witi~i nanometre-siaed Qr Angstram-zo sized aystaDtine domairtsj. such document, ho~revrer, excie~siveD~r concerns the production of resvrbat~le synthetic bane ma#Exiais, which, in view of their in-tended use, are formed in moulds to give s~~iid elements. The only relevant requirement .For such use is the ability of closely repraducing~ the natural bone,.
tissues, so that the synthetic bone graft is integrated and resorted in the saint 2~ tissues. The applications of the canaerne:d material in the arthQpaedic field differ from the present denfat application in that in the fast case the rf,ateriat must comply with stability requirE;rnents, it must be able to eas-ily integrate within the bone and, in soma oases, i't must be able to in-duce bone growth ~direGt relationship between material and celtsj, While ap in the second case the material must interact with mineaai tissue,having chemical and structurat properties different #rom bone, and having a different Qrganic component. Conset~uentlfy, in the,iatter case character-A~,~"~D
I I' ,w,~. mv~Grw:nu~twnuv trt ~s:. -1V~ V ~ t~'3~V . t:~VVVVVVVVV~~ 'tg~ t3~
:~i3~~~3~be7~3f11 ~ ~ N. TEL : 0A0000a~ 01 Gen. 2'301 67: 49 Pi1 istics of the material such as surface reactivity and metastabiiity will have to prevail. Furthermore, the ortt~apaedic applications that irnroive intenrentir~rts on the bone tissue are concerned with a systs:m interaEcting with the blood stream and unaffected by variations induced by the cx~ntaot with the external envi-ronment (such as pH changes nor cnrpositional rrariations afi various finds).
This is right the opposite c~f what happens in the oral environment, and on the tooth surtaae.
Accordingly, the present invention speciftcaily provides the use of an apatite-based nanostructured material of the general fr~rrnuia:
Ca1 o,.xll~Ix~l~C?4)~gs~43H~ z wherein t~! is a nation r3ifferent from Ca~~', B is pan anion di~'erent from R0~3-, A
is chosen from the group cansis~ng of Ow, CO~', F' and Cl-, x is a number from 0 to 9, y is a number from 0 to 5, z is a number frs~m t~ to 2, wherein the said numbers may also be firactionai, with the proviso that the sum of the ~ s charges of the Ca and ~ catlons is equal to tf~a sum of the charges of the F~OQ3', B, A, anti t3H~ anions, wherein the average size of the crystallites of said nanostructured material is comprised between '1 and 50 nm, for the praduGtion of preparations useful for th$ restoration and the protection of dental tissue and, specificaity, fs~r the the~~py of denfine hypersensitivity and for the remineralisatiorz of enamel and dE3ntine. Specifically, the said na-nostructured rr~aterials may show lattice defarrnations and deflects.
in the above definition, the reference to the terrxt "remineralisation~ is intended to include bflth a proper remineralisatidn of enarnei arrd dentine and a reduction of derr~ineraiisatian, or a prevention of demineralisation. P~ an alternative, the present inv~ntian specificadiy provides the use of an apatite-based nanostructured material of the above cieneral farm~rla wherein the vari-ors syrnbois have the meanings specified above, wherein the average size of the crystallites oaf said n~ostructured material is 3o c~ortiprised betweetz 4.5 and 20B nm and said nanostn:ctured materials show lattice deformations and defects, for the production of preparations useful far the therapy of dentine hypersertsi-A~f '~~t~ ~T
i m...r. rvm~crwnvcr~n.rac« v-r .a-iv- v : i~~t ~ vvvvvvvvvv-~ rr~ c~a t.~a~rrot~~xt:
. I~l : H. TEL : 000~6~60 fl1 Gin. ~~: 0'~: 49 P1? .
-'i''c~-tivity and for the rernineralisa~on aF enamel and dentine.
_ fps it is known, apatites represent the rr~ait~ inorganic process of c~ici-fication c~f normal tissue (i.e. enartoel, dentine, ce~°ne~t, bone) and are found associated ~rrith oifier phosphatEC arid nan-pho,~phatic minerals in path~rlogi~ai calcifications. The main one of these compo~nnds, i.e. hydroxy~apatita or hy_ droxyiapatite ~HA~, ha ink the st~aichiam~tric formula Ca~Q(PCt~)s(dN)2 for Ca~~Pt7~ai?H), and being - in its synthe#ic ~bic~compatible) form - the apa#ite rrraterial most Snrideiy exploited at a commerciail Level for several indica#ions in d~eniistry, orthopaedy and maxilio-tacial surgery, is neYer found in a pure state ~ o in the hiola~ical tissues. This is due to the possible Esomorphaus replacements :.
~~e ~a~~, pp~,~- and C~H- ions. Tl~e calcium ion may be totally or partially replaced by a number of cations generally (but not exclusively) having oxida-tion number +2; the phosphate ion (site B} rnay be replaced by carbonate, acid phosphate, pyrophosphate, sulphate, alurninate and silicate ions, and the hydroxyl ion (site A} may be replaced by halogenide, carbonate and oxide ions.
In comparison with the value 1.67 of the stoichiometric hydroxyapatite, biological apatites have a Ca/P molar ratio co3mprised between 1.53 and 1.74 (in particular, comprised between 1.53 and 1.64 for the dental enamel, be-tween 1.62 and 1.68 for the dentine and between 1.72 and 1.80 for the bone).
In general, the oscillations in the CaIP ratio may be caused by: 1 ) lattice va-cancies; 2) ions isomorphically replaced or adsorbed on the lattice surface (for instance, the substitution of the P04s- anion with acid phosphate, which is divalent, bungs about a reduction in the calcium contents); 3) coexistence or presence of possible precursors consisting of phosphates with different CaIP
~s ratio. Among the latter, in particular, there rnay be mentioned (i-tricalcium phosphate {~i-TCP, i.e. Ca3{P04)z, an orthophosphate also known as tribasic calcium phosphate), amorphous calcium phosphate (ACP), octocalcium phos-phate (OCP, Ca$Hz(P04}6~5H20), dicalcium phosphate dehydrate (DCPD, CaHP04~2H20, also known as calcium acid phosphate, dibasic calcium phos-2o phate or dicalciurn orthophosphate). As it m~iy be deduced from the corre-sponding formulas; the Ca/P molar ratio valuEa for some of the phosphates considered are as follows:
HA Ca5{P04)3OH 1.67 (i-TCP Ca3{PO4)z 1:50 25 OCP Ca8Hz(P04)6~5H20 1.33 DCPD CaHP04~2H20 1.00 More correctly, the biological apatites may be described as non-stoichio-metric carbonatoapatites containing, in general as impurities, different ions.
For this reason, biological apatites have variable rnorphology, crystalline charac-3o teristics, chemical and phisico-chemical properiries.
Among the possible phosphates and a~patite materials, either naturally occurring or obtainable by synthesis, suitable for the production of materials for use in the odontostomatologic and biomedic fields, hydroxyapatite [Ca5(P04)30H~ has already been presented as the most widespread material.
In its structure, the phosphate and calcium ions are placed approximately according to a hexagonal prism; in the direction of elongation (crystallographic s axis c) the prism is crossed by a channel having a diameter of 3-3.5 A, hous ing any OH- groups or other possible replacing ions (e.g., fluorine and chlo rine). HA may crystallise in two forms: a monocl'ine form {spatial group P2~/b) and a hexagonal form (spatial group P63/m): In the monocline form, a binary symmetry axis is present along the axis c, vvhile in the hexagonal form the ~o symmetry axis becomes hexagonal.
Some Authors have hypothesised for the biological samples a simul-taneous presence of amorphous calcium phosphate (ACP) and of scarcely crystalline hydroxyapatite. These two phosphates would differ from each other in the intensity of the diffracted X-rays, while having the same broadening of ~5 the peaks. The same Authors hypothesised that the bone tissue contains both phases, the first one to be deposited being ACP; with time, the latter phase would undergo a transformation into microcrystalline HA according to a partial solubilisation process, with subsequent renucleation. The transformation pro-cess of ACP is apparently controlled by environmental factors (ATP, pyro-2o phosphates, Mg2+, etc.), which stabilise with their presence one of the two phases.
Also octocalcium phosphate [Ca$H2(;P04)6-5H20] {OCP) has been found in biological samples. Its crystalline structure appears to be very similar to the structure of hydroxyapatite. Actually, Ot~P may be transformed into HA
25 through a simple chemical mechanism such as the in situ hydrolysis of the already formed crystals. This kind of transformation, considered to be irre-versible, allows foreign ions to be incorporated in the crystal lattice. Such process might also be controlled by a "layer by layer" transformation, meaning that as soon as OCP is deposited in a layer of the thickness of a unit cell, this so is hydrolysed and transformed into two layers consisting of two unit cells of HA. OCP may be considered to be a mediator between the aqueous phase and the apatitic phase. The kind of product obtained (i.e. OCP or HA) depends on the relative rates of the OCP precipitation process and of the transforma-Lion thereof into HA.
As concerns the possible cation replacement in the apatite formula, although this problem has been studied in thE: literature, the only information s of some interest is that the solid solutions are structurally more ordered when the size of the replacing cation is large. It is not possible to theoretically fore-see the ability of calcium of being replaced by chemically and crystallographi-tally similar ions; in addition, also when this is the case, the extent of the iso-morphaus replacement may be partial. However, it is ascertained that the ~o preparation method has a substantial influence on the extent of the replace-ment.
In an aqueous environment and under conditions similar to the physiological ones, the Mg2* ions inhibit the hydroxyapatite precipitation and promote the formation of (i-tricalcium phosphate. Actually, when the magne-~s slum concentration exceeds 10% the simultaneous formation of ~HA and ~i-TCP occurs, the latter being the only product that precipitates when the con-centration exceeds 25%. The fact that magnesium replaces calcium in (i-TCP
is made evident by the displacement of the X-ray diffraction peaks in the pow-der diffraction spectra of the same samples.
2o However, the magnesium contents in biological apatites is very low {about 1 %), and is limited to a surface deposition. This is evidenced by the fact that during the initial dissolution stage oi' biological apatites (both bone apatite and tooth enamel) a prevailing relea;>e of magnesium ions may be observed. In the apatites with magnesium replacement, the lattice parameters 2s show a slight contraction, and the infra-red {LR.) spectrum bands are shifted towards lower frequencies, in accordance with the lower atomic mass of mag-nesium and with the different energy of the Mg-O interaction.
Strontium is present in biological apa~tites only at the impurity level, and may replace calcium, thus causing an expansion of the a and c axes. The 3o presence of this element in apatites for odontostomatological use is consid-ered to be important in connection with a possible cariostatic effect thereof (in addition to the hypothesised effect of reduction of the dentine sensitivity), and confers on the apatite a lower solubility and a higher resistance to thermal treatments.
As concerns barium, this cation does not isomorphicaily replace cal-cium in the whole concentration interval. As a matter of fact, the variation of the lattice parameters results in an expansion of the cell parameters.
As pointed out before, the basic structure of hydroxyapatite may also be substituted with anionic groups, in particular, in carbonatoapatite the car-bonate ion may replace the hydroxyl ion (site .A) or the phosphate ion (site B) or both. Although the replacement of the carbonate ion in the site B is prefer-~o ential in the biological samples, it is also possible to obtain carbonatoapatites of the type A synthetically, by means of high temperature reactions. On the other hand, ca~bonatoapatites of the type B o~r mixed type A + B are mainly obtained by precipitation from solutions.
The presence of the carbonate ion in the different sites, which is ~5 hardly detectable by X-ray diffractometry, may be evidenced through LR.
spectroscopy, since the position of the absorption bands of the carbonate ion directly depends on the occupied site. The presence of the carbonate ion in hydroxyapatite modifies the lattice dimensions: if the said ion occupies the A
site an increase in the a parameter is obtained, as a consequence of the 2o greater size of the C032- ion with respect to the OH- ion; if, on the contrary, the carbonate ion occupies the B site the same parameter undergoes a con-traction, due to the smaller O-O distance in the C032--ion with respect-to the P043- ion. In addition, it has been observed that the inclusion of the carbonate ion in apatite results in a reduction and in a diifferent morphology of the crys-25 tats, which appear to change their shape from a needle-like one to one of comparable length in the various crystal dimensions. The solubility increases as well, while the thermal stability decreases.
In fluoro- and chioroapatites the F- and CI- ions, respectively, replace the hydroxy ion; the said replacement, theoretically, may be total. Fluoroapa-3o tite is characterised by an increase in the crystal dimensions, by a decrease in the a parameter of the unit cell, by a lower solubility and by an enhanced thermal stability. The lower solubility, and therefore the higher lattice stability, of the fluoroapatites substantiates the present use of the fluoride ion in the therapy of bone affections and of dental caries.
Chloroapatite is characterised by an expansion of the a side and a contraction of the c side of the unit cell. The different lattice behaviour of chlo-s roapatite with respect to fluoroapatite derives from the remarkable difference in ionic radius between the two halogens: in l7uoroapatites the fluoride ion is placed on the senary axis located on the plane defined by the three calcium ions, while in chloroapatites the chloride ion is slightly displaced from the plane of the metal ions. This phenomenon results in the above-mentioned parameter variations of chloroapatite, while the crystallinity does not seem to be significantly affected, even if the thermal slrability decreases: It is possible to observe the presence of solid solutions t~etween fluoroapatites and hy droxyapatites and also between chloroapatites and hydroxyapatites in the whole concentration range; solid solutions may also occur befinreen fluoroapa ~5 tites and chloroapatites.
The non-stoichiometric character of biological apatites may also be caused by the presence of the acid phosphate ion HP042-; this ion is con-tained specifically in the tooth enamel, in amounts comprised between 5% and 15%, and is effective in increasing the hydroxyapatite solubility. The presence 20 of acid phosphate in biological and synthetic apatites is not easily detectable, since the carbonate ion, which is almost aiways present, overlaps the LR.
absorption bands and causes a similar variation of the cell parameters: The original presence of HP042- may be evidenced by the pyrophosphate forma-tion, obtained by heating the apatite samples between 400 a 500°C.
25 According to some specific embodiments of the invention, therefore, the M cation is chosen among the following ones: H+, Na+, Mg2+, K+, gr2+, Ba2+ and Fe2+, and preferably the x value is comprised between 0 and 2. The B anion is chosen, preferably among C032-, HP042-, HC03-, and P2074-, while the y value may be comprised, for instance, between 0 and 2. As far as so the A anion is concerned, according to a specific choice the latter is absent, the z value being equal to 0 (hydroxyapatites), while according to another specific choice the A anion is F-, with z = 2 (fluoroapatites).
The nanostructured apatites according to the invention may be pro-duced by any one of the several known methods, already in use for the pro-duction of nanocrystalline materials, such ass the synthesis methods from atomic or molecular precursors (e.g., chemical or physical vapour deposition, condensation in gas, chemical precipitation, reactions from aerosol), the methods of production from mass precursors (e.g. by mechanical attrition, by crystallisation from the amorphous state, by plhase separation), and the meth-odg borrowed from nature (i.e., biologically mirnicked systems).
The conventional deposition of layers of material by electrolytic proc-esses or by vapour condensation has been exploited in recent times to de-posit materials of nanometric dimensions with remarkable control and accu-racy. The new or improved methods inctude~, in particular, increasingly ad-vanced mono- or multi-bath systems for elecl:rodeposition and new chemical 15 or physical vapour depcssition methods, such as molecular beam epitaxy (MBE), metal-organic chemical vapour deposition (MOCVD) and chemical vapour synthesis (CVS). Such methods not only afford an accurate control on the chemistry and the thickness of the layer deposited on a nanometric scale, but they also afford, in some cases, to control the nature of the interfaces 2o within the same layers (t_.E. McCandlish, D.E:. Polk, R.W. Siegel, and B.
H.
Kear, Multicomponent Ultraflne Microstructure:;: Mater. Res. Soc. Symp. Proc.
132 (1989); G. Gumbs; S. Luryi, B. Weiss, and G.W. Wicks: -Growth, Proc-essing and Characterisation of Semiconductor Heterostructures: Mater. Res.
Soc. Symp. Proc., 326 (1994}).
25 Several new opportunities also exist in the meld of the production of nanophasic materials assembled from atomic clusters synthesised through physical and chemical methods. For instance, chemical precipitation repre-sents one of the conventional methods for synthesising ultrafine powder or colloidal suspensions that has been successifully applied in the synthesis of so nanometre-sized clusters with narrow dimensional distribution, for instance by applying the sol-gel technique or the inverse nnicelle method: Also many high-temperature gas reaction methods are presently available for the synthesis of nanometric clusters, or of nanostructured powders of bigger size (R.W. Siegel, 1991, loc: cit. ).
As far as the latter group of techniques is concerned, the synthesis of nanocrystalline materials by in sifu consolidation, under vacuum, of ultrafine particles condensed in the form of nanometre-sized gas starts when a precur-sor material, be it an element or a compound; is evaporated into a gas main-tained under low pressure, generally well below 1 atmosphere. The evapo-rated atoms loose energy as a result of the collisions with the atoms or mole-to cules of the gas, and undergo a homogeneous condensation suitable to form clusters of atoms in the highly supersaturated area close to the precursor source. In order to keep the clusters dimen:>ions small while reducing to a minimum the growth with further atoms or molecules or the coalescence among the clusters, it is necessary to rapidly remove the previously nucleated ~5 clusters from the highly supersaturated zone. Since the clusters are already suspended in the condensation gases, this may be readily obtained by pro-viding for the conditions to displace the said gias, for instance by natural con-vection or by forced circulation. The gas-suspended clusters are then con-veyed towards a collecting surface (the collection occurring by thermophore-2o sis} and are then placed in a piston-anvil device for consolidation. It is also possible to cant' out, for instance, a direct deposition of clusters as thin ~tms or filaments.
Only three basic parameters, working in connection with each other, control the atom clusters formation in the gas condensation process described 25 in the foregoing (McClandish et al., 1989, loc, cif.), namely: the rate of atoms supply to the supersaturation area wherein thE; condensation occurs, the rate of energy removal from hot atoms through the condensation medium, i.e. the gas, and (Siegel, 1991, loc. cit.) the removal rate of the previously nucleated clusters from the supersaturation area.
3o The mechanical attrition method (i.e. (lattice destabilisation) allows to produce nanostructures, rather than by cluster coalescence, through the de-composition of coarse-grained structures, caused by a severe mechanical ~CA 02338021 2001-O1-17 deformation. The nanometre-sized grains fornn a nucleus within slip bands of highly deformed precursors materials, thus transforming a coarse-grained structure into a nanophasic one. A great deformation is normally obtained by means of a high energy crushing; but it may also occur as a consequence of s surface wear phenomena (E: Hellstern, H.J. F'echt, Z. Fu and W.L. Johnson., J. Appl. Phys., 65 (1989); C.C. Koch, Nanostructured Mater., 2, 109 (1993)), or it may be obtained through other methods of introduction of high deforma-tion densities (R. Valiev, in Mechanical Properties and Deformation Behaviour of Materials Having Ultra-Fine Microstructures, M. Nastasi, D.M. Parkin, ,and ~o H: Gleiter. 303 (1993)}. In the course of the hard mechanical work on the precursors it is also possible to react different materials so as to have them form new phases and compounds.
This quite direct and relatively easy method offers a ready access to the ultrafine grain dimensions useful for the purposes of the invention, and ~5 allows to produce commercial amounts of material. The method has been used for the synthesis of the nanostructured apatite materials according to the invention that underwent the comparative experimentation described further on. The nanostructured apatite material accoirding to the invention was pro-duced starting from apatite with microcrystalliine structure through lattice de-_ 2o stabilisation in a controlled environment, under high energy, by subjecting the starting material to a high mechanical energy transfer treatment. The latter is carried out into a cylindrical reaction chamber by means of high energy im-pacts from hard balls contained within the same chamber. The kinetic energy of the balls is generated by a rotation rnovemE;nt of the chamber with respect z5 to its main axis and by a revolution movement of the same with respect to an axis parallel to the main one. The transformation of kinetic energy into me-chanical energy of lattice destabilisation occurs through impacts between the balls and the starting material. The chamber may work either in air or in inert gas or under vacuum, down to a pressure value of 10-~ torr, or with liquids 30 (alcohol, ethers, oils and other organic molecules).
The above method reduces the crystallites dimension through subse-quent introduction of lattice defects (which may be evaluated by means of X-ray diffraction techniques). In particular, the n~anoapatite material obtained by the disclosed synthesis method and employed in the applications reported herein shows an average dimension of the crystallites of about 15 nm, with an average strain ranged between 10-5 and 10-2.
s The apatite-based nanocrystalline products according to the present invention represent a material that simulates the dentine composition and is perfectly compatible, both biologically and structurally, with the dental tissue.
The material is able to efficiently become stably integrated with the dentine, thus making it totallx impermeable. The dimensional features, the properties of surface activity and the defective contents of the nanoapatites, preferably obtained according to the previously disclosed method, allow to easily obtain both the mechanical filling of the tubules and the fixing reaction with the tubule surface {i.e. remineralisation). Therefore, the clentine sensitivity resulting from the hydraulic conductivity through the tubule structure of dentine is practically removed. As noted in the foregoing, the said permeability is a critical factor in the dentinal pain stimulation theory, as the presence of exposed and open tubules causes, when suitable external stimulii are present, the movement of dentinal fluid, perceived at the neural structure level as a pain stimulus.
According a preferred embodiment of the invention, the nanocrystal-20 line apatite materials are protected from acid attack by subjecting them to a treatment with protective aqueous solutions containing tartaric acid andlor its - salts, such as; e.g., aqueous solutions contaiining potassium sodium tartrate {or Seignette's salt, or Rochelle's salt, NaC>OC(CHOH)2COOK~4H20) and hydrous calcium acetate {Ca{CH3C00)2~H20;~, or, in the alternative, with a 2s solution containing tartaric acid (HOOC(CHOH~ COOH). Preferably, a 0.1-1.0 M solutioh of potassium sodium tartrate and a 0.1-1:0 M solution of hydrous calcium acetate are used in a sequence, by dipping therein the material ac-cording to the invention, preferably at 37°C, for periods of time comprised between 5 and 30 minutes. Specifically, the rjanoapatite is immersed in the 3o first solution and kept therein for 5 minutes, then it is withdrawn from the first solution and immediately immersed in the second solution for 20-30 minutes.
The material can also be individually treated with one of the following ii K1,1.. 1~U:~ ~ ~.Yt1-hll~tWCaIt:IV U4 ::?'?- lU- U : 'T : ij.. j ..
UIIUUUt)Ui3UU-> +4a t3J '.,~.~~~bti:~: # 1~
DR : t~l. TEL t SflflC~00i~3~ 01 Gen. 2~0t 07: 50 Flew agents: rncno-, bi-, tri-, tetra-, polycarba~cyiated caiciurn gluconate in aqueous solution at a co~aer~tration of 0.0~ _5°~ by v~eiyhtt or in aE:cohoiic or hydroatco-hoiic solution at a r"ancentratlon 'sn the range from O.t3l °~ and 15~k by weight;
or with art acetic andfor rrialic a~nd~or hyalt~ronic solution of ohitosac~ at a ccsn-s centration in the rarsge from 5°~ to 2(3°~ by vrei~~ht; or with a solution of human, bovir~, swine, rat or turi~ey tendorx collagen, either isotonic or not, at a con-centration in the range from ~.5a/a to 5°~o by weight. The said treatments result in a protection of the r~anostructure~i materi~a from acid environments. The said mater;at, however, rnay also be used vtrith~out any further treatment.
~ o the invention Rather concerns compo:~tiar~ for the #herapy of dentine hypersensitivity and for the r~e~roinsr~eiisafion of enamel and dertti~
(~mprisirtg the apatite-Eased nanostruclured materials desait5e~d in the far~egoing, toge~er-w~h further possible ingredients and exclpients of the ;same kind as those used in p~aa-rations frx dental h3rc~ier~ and for the therapy of the oral cavity. The oampositions, ~ s that are pre~r ably in the fame of ~too~te, haste, get, suspension or solution, preferably an from ~.5°!o to 50°k by weight of nanocrystaliine ratite rrtateriai, either treated with protect~re agents or not Fur~~ preferred flees of the cornpo- .
sitions according to the inventjon, with particular reference to oral fonnutations in the get form, are ' Ced in the fuhher dependent dairr~s.
2o Some specific embodiments of the irwention are described below for merely itluatrative purposes, together with the results of tine experimental studies carried out on the proposed rranvstr«cfured tarQducics, ir~ciuding com-parati~re tests with other non-nanocrystalline <~patite materials.
EXAMi'L~ 'E
A rnicracrystaliine carbonate-apatite materiat, nor.-stoiahte~rt7etric as regards the hydroxy ion, was subjected to a lattice destabilisation treatment in a controlled environment, under high energyi, by using the r~eact~on charrrber r~escribed in the foregoing. The resulting pn~duct ~nanospatite) is character iced by average crystallite sues of 15-2C3 nrn anct by an average rniorostrain so content comprised between '! ~~' and 1 Ct's.
A portion of the nanocrystatline ap~~tite thus obtained which will be referred to in the fooltowing as nanoapatite 't or r~ano 't ) has also been sub-~~~ 'r~D ..: . ~
jected to treatment with tartrate in order to increase its resistance to acid at-tack in the conditions of use in the oral cavii;y. To that aim, the nanoapatite was treated with a 0.1 M aqueous solution of potassium sodium tartrate (Sei-gnette's salt, Carlo Erba, Milano) at 37°C for 5~ minutes, and then with a 0.1 M
solution of hydrous calcium acetate (Carlo Erba, Miiano) at 37°C for 20 min-utes.
An apatite material of the same nature and composition as the mate-rial of Example 1 was subjected to a similar !lattice destabilisation treatment, with a different value of the energetic content transferred. The resulting nanoapatite was characterised by average crystallite dimensions of 10-14 nm and by an average microstrain content compri:>ed between 5~10' and 10'x.
Also in this case, a portion of the nano~crystalline apatite thus obtained (i.e. nanoapatite 2 or nano 2) was treated with potassium sodium tartrate and ~5 hydrous calcium acetate, according to the same procedure of Example 1.
~ Dentine permeability test The effectiveness of the nanocrystailine apatite products according to the invention in the treatment of dentine hypersensitivity was evaluated in 2o terms of reduction of the hydraulic conductance within the dentine tubules, according to a well established protocol (Pas~hley, 1990, loc. cft.), in agree-ment with the international literature. In ordear to carry out such test, sound human molars have been used, extracted for orthodontic reasons from young patients, in order to avoid the problem of sclE;rotic dentine. Each crown was 25 properly separated from the root and cut in order to obtain a crown segment deprived of the occlusal enamel. After removing the pulp tissue, the crown segment was fixed by means of adhesive onto a Plexiglas base, with the flat surface of occlusal dentine facing upwards. The base was crossed through its entire thickness by a tubular stainless steel sE;gment, projecting into the pulp 3o cavity in order to provide the hydraulic connection, below the Plexiglas base, with the hydraulic conductance measuring device. The latter was made of a simple hydrodynamic device consisting of a set of capillary tubes filled with deionised water and connected through the tuibular stainless steel segment to the pulp cavity. The passage of water from the pulp cavity to the occlusal surface through the dentine was evidenced by the displacement of an air bubble in a graduated microcapillary tube located in the hydrodynamic sys-s ~ tem.
The tests reported below where carried out; by means of the de-scribed equipment, by applying on the exposed dentine surface a car-boxymethyl cellulose-based gel, to which the single active ingredients under test were added in tum. Each batch of gehwas obtained by dissolving fi g of ~.o carboxymethyl cellulose at 50°C in an aqueous solution containing 0.2% by weight of paraben, and-stirring the solution until a transparent gel, of the right consistency, was obtained. The various products under test were mixed to 3 ml aliquots of the gel thus produced, according to the following scheme:
1. control, consisting of the only gel vehicle;
15 2. commercial microcrystalline hydroxyapatite (Merck, Darmstadt, Germany, Art. 2196);
3. commercial microcrystalline hydroxyapatite treated with potassium sodium tartrate and hydrous calcium acetate as described in Example 1;
4. nanoapatite 1, produced according to Example 1;
20 5. nanoapatite 1 treated with potassium sodium tartrate and hydrous calcium acetate according to Example 1;
s Data reported in the literature show that several toothpaste products possess some desensitising action, which is often independent of the kind of active ingredient employed (D.G. Gillam, J.S. Buiman, R.J. Jackson, H.N. Newman, Comparison of 2 desensitizing dentifrices with a commercially available fluo-ride dentifrice in alleviating cervical dentine sensitivity, J. Periodontol., 67:
~0 737-742, {1996)). Very often, also the other components of the toothpaste play an important role, in that they are able themselves to seal the dentine tubules. In addition, the placebo effect plays a role considered by someone to be a primary one.
The most studied and well-known products for home therapy include 15 dentifrices containing strontium chloride hexahydrate. The latter, as pointed out in the foregoing, is used in view of its ability of closing the dentine tubules, rather than for its activity in depressing the den~tinal nerve fibres stimulation. It is believed that the Sr2+ ion reacts with the ap<~tite matrix of the dentine, thus forming with said matrix an insoluble strontium-apatite. The latter settles as a 20 layer of microcrystals, that are able to reduce the functional diameter of the dentine tubules. Also stannous fluoride is believed to act by forming insoluble complexes with- dentine {i.e. fluoroapatite or calcium--fluoride), which com-plexes are able to obstruct the tubular lumen. As tar as potassium citrate is concerned, it has been shown that the citrate ion chelates the calcium con-es tained in the tooth hydroxyapatite, thus resulting in the formation of a soluble calcium citrate {Misra D.N., Interaction of citrate Acid with Hydroxyapatite:
Surface exchange of ions and precipitate of calcium citrate, J. Dent. Res., 75(6), 1418-1425, June 1996).
In this connection, other dentifrices and desensitising preparations 3o have been proposed, which, rather than being based on products that form insoluble precipitates by reacting in the oral environment, are based on the direct use of apatite, i.e., the basic material making up the dentine, in the microcrystalline state. For instance, the US patent No. 4634589 (Wurttember-gische Parfumerie-Fabrik} discloses the use oaf a crystalline apatite having a particle size of less than 8 pm as an abrasive; and polishing agent, active in the treatment of dentine hypersensitivity and also having a remineralising s action on the dental tissue. The dentifrice formulation proposed contains at least 15% by weight of such ingredient. Similarly, the European patent appli-cation No. 0346957 (Unilever) discloses the use of hydroxyapatite as a de-sensitising abrasive agent for dental products. In this case, the hydroxyapatite particle size is 1-15 Nm, and the formulation proposed also comprises a source of potassium andlor strontium {as a further desensitising agent).
The treatment of dentine hypersensitivity by home therapy, however, has the drawback of requiring long periods of time (often more than four weeks) to reach any appreciable clinical results. fn addition, the said results are often only partial, as a great amount of co~-operation is required from the 15 patient. In view of that, the treatment of dentine hypersensitivity is preferably carried out at the dentist's consulting room, by directly treating the affected tooth (or teeth}. Also in this case, the main aim is to occlude the open dentine tubules. Several techniques and materials have been proposed to that aim, according to the degree of seriousness of the symptoms. Such techniques can 20 be schematically divided into four main groups: 1 ) mechanical treatment of the sensitive surface in order to obtain a new smear layer; 2) application of agents effective in occluding the dentinal tubules, either directly or by forming insolu-ble precipitates; 3} impregnation and obstruction of the dentine tubules by means of adhesives; 4} application of dental restoration materials, optionally 2s together with intraoral devices for sustained release of fluorine. In the most serious cases, as well as in those cases where any other kind of therapy is ineffective, the dental restoration and the endodontal treatment are often in-eluded in order to finally solve the problem.
As regards the first one of the treatnnents mentioned above, since 3o dentine is not permeable when a suitable smear layer is present, it is often possible; by simply applying an abrasive paste (such as the Nupro paste} and by working the dentine surface by means of silicone or rubber cups, to obtain a thin and uniform smear layer and, consequ~:ntly, the obstruction of the tu-bules. Although simple, such treatment does not give long-lasting results, as the smear layer is soluble (specially in an acidl environment), and therefore it may be easily removed by the patient. An incorrect brushing of the teeth or the ingestion of acid liquids (such as fruit juices, beverages, etc.) are often suffi-cient to cause the smear layer removal. Therefore, the adoption ofi the above treatment is limited to non serious cases, e.g. to treat patients after a perio-dontal intervention with exposure of limited deintine surfaces and without any previous history of dentine hypersensitivity.
~o The second kind of medical treatment mentioned in the foregoing consists, for instance, in applying oxalates (such as potassium, iron or alu-minium oxalate, and oxalic acid) on the affected dentine surface. Such agents may react with the dentinal apatite constituents, thus forming insoluble cal-cium oxalate microcrystals on the surface and in the interior of the dentine ~s tubules. The solutions containing the concerned agent may easily be applied on the dentine surface by means of little brushes, and they may be left in situ for 2-3 minutes, this period of time being enough for the said microcrystals to form. It is to be noted, however, that this technique may involve some prob-lems due to the toxicity of oxalates. Also silver nitrate, another agent em-2o ployed for a long time for the same purpose, has a mechanism of action based on the formation of precipitates (Ag chloride) which occlude the dentine tubutes. _ ..
The same kind of therapeutic approach also includes the direct appli-cation of microcrystalline apatite, as mentioned in the foregoing in connection 25 with products for home therapy. More specifically, the medical treatment in-cludes the use of an ultramicronised apatite, ouch as that disclosed, for in-stance, in the Italian patent No. 1271874, where: the particle size of about 70%
of the apatite microcrystals is less than '! pm (0.2-1 Irm}. Such product is con-sidered to be more active than the micronisedl apatite products disclosed in 3o the foregoing, on the basis of the simple consideration that the dentine tubules have an average diameter of about 1.3-3.5 um. Therefore, crystals having slightly submicronic size may, theoretically, pE;netrate within the dentine tu-WO 00/03747 PCTIIT99l00224 bules, thus performing a better mechanical occlusion. On the contrary, the micron-sized crystals disclosed in the two previously cited patent documents may only create an occlusive layer on the dentine surface, without penetrating into the tubules.
s Considering the medical treatments, however, the procedures be-longing to the third group referred to above, consisting in dentine impregnation by means of adhesive resins, are considered to be more effective. The resin impregnation technique, proposed by Nordenvall and Brannstrom (K.J. Nor-denvall, M. Brannstrom, In vivo resin imprecanation of dentinal tubules, J.
~o Prosthet. Dent.; 44:630-637 (1980)), has become extremely reliable only after the introduction of dentinal adhesive systems consisting of highly hydrophilic resins, which are able to infiltrate through the dentine and to penetrate within the tubules for some tens of microns. tt has been shown that the dentine sur-face, treated with etching acid (for instance, with phosphoric or malic acid) ~s becomes demineralised up to 4-10 Nm of depth, and rich in partially collapsed collagen fibres only. This treatment enhances the penetration of the resin (usually, a primer) within the dentine tubules and within the collapsed colla-gen. The resin, by penetrating into the tubule;>, forms long plugs (referred to as resin tags) which occlude the tubular lumen and reduce the dentine per-2o meability: In addition, the resin impregnates .and occludes the small lateral channels as well (as it has recently been confirmed by some studies by scan-ping electron microscopy); thus contributing to the formation of a thick resin network effective in stably blocking any movernent of the dentine fluid. A by brid layer made of resin and collagen is thus formed. From the point of view of 2s the mechanism of action, it is not clear whetlher other factors co-operate in reducing the sensitivity, in addition to the tubules occlusion and the conse-quent permeability reduction (which is, very Ilikely, the main mechanism of action). It has been hypothesised that some of the components of the dentinal primers also have a pharmacological action such as to reduce the symptoms.
3o At the present state of knowledge, they impregnation treatment of the exposed dentinal surface with resin is to be considered specific for patients wherein few dental elements show a medium or serious dentine hypersensi-_g-tiVity.
Finally, in the occurrence of widespread and serious dentine hyper-sensitivity, a distinction has to be made between lesions with deficiency of periodontal tissue, wherein surgery represents the treatment of choice, and lesions with extensive enamel loss, wherein a conservative dental restoration is indicated. For the latter purpose, the same dentinal adhesive systems of the previously disclosed method may be used, followed, obviously, by the appli-cation of a composite resin-restorative material; in the alternative, photocuring glass-ionomer cements may be used. This kind of intervention, as pointed out before, is reserved to cases showing a marked deficiency of tissues, or when the hypersensitivity is extremely serious. The further therapeutic step is, obvi-ously, the endodontic treatment of the affected tooth.
In addition to the well established treatments referred to in the fore-going, further literature, mainly patent publications, proposes (besides the ~5 micronised and ultramicronised apatite materials mentioned above) the use of amorphous calcium phosphates, both in order to remineralise (and, optionally, to fluoridate) the dental tissue, and in order to reduce the dentine hypersensi-tivity. The US patent No. 5268167 {American Dental Association Health Foun-dation) proposes, to such aim, the use of amorphous calcium phosphates (i.e., 2o ACP or amorphous calcium phosphate; ACPIF or amorphous calcium fluoro-phosphate; ACCP or amorphous calcium carbonate phosphate). According to the disclosure; the said amorphous salts, or solutions that may originate such salts by precipitation, are applied on the dental tissue surface, and settle thereon and within the same tissue. The amorphous salts are then converted 25 to crystalline apatite, thus performing a remineralising action and reducing dentine sensitivity. In the same frame, the PCT patent application No. WO
94/04460 (American Dental Association Healtlh Foundation) also presents the ACCPF phosphate (i.e., amorphous calcium carbonate fluorophosphate), as a new compound particularly interesting for the same purpose.
3o In the light of the prior art referred to above, it is an object of the pres-ent invention to provide a biocompatible product substantially based on apa-tite, able to satisfactorily comply with various therapeutic requirements in the ,:.....~n~-rrn-nn:~vLt~:v u9- :Za-10--0 : 7::39 : OOU0000000> -t-5~;~ 8:3 :2:3f~:# 9 I~. TEL : ~0~00IO~F30 fli Gen. 20~i 67: 48 r 9 field of dental cage and, frstiy, to effectively and Lastingly counteract dQrr#ine hypersensitivity, by deeply occhding and cemE:nting the derctina tubules, and by exerting a desensitising action that withstands the attack of any chemically aggressive agent presertt in the bras environment, such as acid t~evareges and food.
tn a4cordance with the invention, it has been found that the apatite materials characterised by a nat~a~ysta111ne, preferably defective structure {as opposed to the lcncv~m amorphous and sr~ierocrystaitine Structures, including the uitrarnlcronised forms) lend themselves m~c~ch better to the objects men-30 tinned above, as they allow to achieve remarikable therapeutic results, up to the complete suppression of det~ine hypersensitivity and, in addition, with a considerable ren~ineralisa~on of the denfai (issue. Such results are made possible by the unir~ue features of the cryst;~lline nanostructures, that sub-stantiate the great potential of these advanced materials in many applicative ~5 fields.
In general, ate naraocrystaaiine materials ere artificially synthesised rnaterials, cha~ractertsecD by a constituent phase, of by granular structures, modulated bn a Length scale normally smaller' than 10Q rim. According to the number of dirnensions in which they show a nanametric s~uc~ure, the nano ~c crystalline materials are considered to be with dimensionality eguai to zero t' (clusters of atoms - for instance, dispersed inn a non-nanocrystaliine matrix , fiiarrtents ar tubules), ~Nith dimensicnaiity on~i (multilayers, i.e., layers which are nanornetric in t1-~e only direction of tt~e tt~tiacitnessj, with dimensionallty two tgranular s~uperposltions, ultrafine, or buried layers), or with dimensionafity three ~nanophasic materials, wherein all of the ronstituerrt phases are of nanometric proportions on three dirnensions',t (R.111~, Siegel, in Ma~teriais Sci-enc~ and Technology, Voi. 'I5: Processing oil Metals and Alloys, R_li'V_ Calm, 583 (199~i ~). '1~he particular facnperties c~f the nana~crys#atline materials in com-parison with the conven~i~nai materials res~rEt from the cambirration of their 3o three basic and distinctive features, namely: ij atomic domains (i.e., clusters, grains, I$yers or phases) limited in space to less than ~i00 rim; ii) s#gn~cant atornic fractir~ns asscxiated writh irrter~ace erw~iranmer~ts (that is, grain bounda-'~~g ~~T
ries, interfaces and heterophase; and free surfaces); and iii) interactions among their constituent domains.
At present, it is possible to produce inexpensively, by means of sev-eral physical and chemical processes, clusters of atoms in the range of the nanometric dimensions, containing from -hundreds to tens of thousands of atoms, in such a number as to be assemblablle into materials which advanta-geously incorporate into one single material a multiplicity of effects due to the dimension. The said effects range from the electronic effects of quantum di-mension caused by the spatial confinement of the valence electrons, to the suppression of mechanisms of lattice defects, such as the dislocation genera-tion and the migration towards limited granular dimensions. The basis of the particular pertormances of the nanostructured materials is to be found in the fact that a physical property of matter becomes altered when the entity or the mechanism responsible for such property (or the combination thereof) are confined within a space (defined by the dimension of the atoms set) smaller than a given critical length associated with such entity or mechanism. There-fore, for instance, a metal that is conventionally ductile owing to the usual ease in creating and displacing dislocations through the crystal lattice thereof wil! become remarkably harder when the grain size is reduced down to a criti-2o cal point wherein the dislocation sources are r~o more able to work at the low levels of the applied stress.
in addition to being characterised by t:he dimensions- of-their-ultrafine domain (i.e. grains or layers), the nanocrystalline materials are also charac-terised by the high number of interfaces they contain. Since the number of interfaces present in the nanocrystalline materials is much higher than in the conventional materials, a suitable control, in t;he course of the synthesis;
on the nature of the interfaces created between the constituent phases leads to a control on the nature of the interactions through the said interfaces. In order to have an idea of the importance of the interface environment in a nanocrystal-line material it is sufficient to consider; for instance, that in a material with an average grain size of 5-10 nm the percentage ~of atoms comprised in the grain boundaries is in the range from 15 to 50%.
...... .w~a.a n-mc.~W .tiClY V~ :l:L-lll- V : 'I~~1) : VVV~1VVVVVV-~ ~~ tS~
~4:3JJ't~t~:~flV
h1. Tt'~'-.~ : 000~000000 (31 G~t't: r~~01. 07: d8 P26 In view of the general features of they nanocrystaliine materials re-ferred to in .the faregain~, for the use prop~osec~ according to the invention the apatite-based nanostructured rr~ateriais appe~~r to possess, firstly, the most suitable gt.anufa~r dimensions to easily and deeply penetrate within the dentine ~ tubules which, as pointed out before, have disameters in the range of 1.3-3.~
Nm). In addition, as pointed out before, the concerned materials show specific physiemiaal properfies connected with #h~eir nanocrystatiine nature, such as the re~arkatxle sur~ac~ lira! reactivity and the hygrnscapiaty, which not t~niy allow the material to penetrate mechanically within the tubules, but to also cause it to cement the internal surfaces thereof, both bar swelling and by readily reacting with the natural tissue, and recrystaliising as a result of the rnetastabie character of the nanocrystalline system. Actually, the tatter may have, in this spec~~fic case, a high defective content Apafite-based materials characterisecl by a nanoaystaHine structure appear to have somehow been descrJbed in the PCT patent application No.
9IV0 9711725 ~Etex Gor~r. ), concerning the to~v temperature synthesis of a law crystaJtinity apattte for use in bone tissue gram, Actually, the definition of claw crystailinEty material" given in such text gene~ricatly includes bath amorphous materials and nanocrystatiine materials (witi~i nanometre-siaed Qr Angstram-zo sized aystaDtine domairtsj. such document, ho~revrer, excie~siveD~r concerns the production of resvrbat~le synthetic bane ma#Exiais, which, in view of their in-tended use, are formed in moulds to give s~~iid elements. The only relevant requirement .For such use is the ability of closely repraducing~ the natural bone,.
tissues, so that the synthetic bone graft is integrated and resorted in the saint 2~ tissues. The applications of the canaerne:d material in the arthQpaedic field differ from the present denfat application in that in the fast case the rf,ateriat must comply with stability requirE;rnents, it must be able to eas-ily integrate within the bone and, in soma oases, i't must be able to in-duce bone growth ~direGt relationship between material and celtsj, While ap in the second case the material must interact with mineaai tissue,having chemical and structurat properties different #rom bone, and having a different Qrganic component. Conset~uentlfy, in the,iatter case character-A~,~"~D
I I' ,w,~. mv~Grw:nu~twnuv trt ~s:. -1V~ V ~ t~'3~V . t:~VVVVVVVVV~~ 'tg~ t3~
:~i3~~~3~be7~3f11 ~ ~ N. TEL : 0A0000a~ 01 Gen. 2'301 67: 49 Pi1 istics of the material such as surface reactivity and metastabiiity will have to prevail. Furthermore, the ortt~apaedic applications that irnroive intenrentir~rts on the bone tissue are concerned with a systs:m interaEcting with the blood stream and unaffected by variations induced by the cx~ntaot with the external envi-ronment (such as pH changes nor cnrpositional rrariations afi various finds).
This is right the opposite c~f what happens in the oral environment, and on the tooth surtaae.
Accordingly, the present invention speciftcaily provides the use of an apatite-based nanostructured material of the general fr~rrnuia:
Ca1 o,.xll~Ix~l~C?4)~gs~43H~ z wherein t~! is a nation r3ifferent from Ca~~', B is pan anion di~'erent from R0~3-, A
is chosen from the group cansis~ng of Ow, CO~', F' and Cl-, x is a number from 0 to 9, y is a number from 0 to 5, z is a number frs~m t~ to 2, wherein the said numbers may also be firactionai, with the proviso that the sum of the ~ s charges of the Ca and ~ catlons is equal to tf~a sum of the charges of the F~OQ3', B, A, anti t3H~ anions, wherein the average size of the crystallites of said nanostructured material is comprised between '1 and 50 nm, for the praduGtion of preparations useful for th$ restoration and the protection of dental tissue and, specificaity, fs~r the the~~py of denfine hypersensitivity and for the remineralisatiorz of enamel and dE3ntine. Specifically, the said na-nostructured rr~aterials may show lattice defarrnations and deflects.
in the above definition, the reference to the terrxt "remineralisation~ is intended to include bflth a proper remineralisatidn of enarnei arrd dentine and a reduction of derr~ineraiisatian, or a prevention of demineralisation. P~ an alternative, the present inv~ntian specificadiy provides the use of an apatite-based nanostructured material of the above cieneral farm~rla wherein the vari-ors syrnbois have the meanings specified above, wherein the average size of the crystallites oaf said n~ostructured material is 3o c~ortiprised betweetz 4.5 and 20B nm and said nanostn:ctured materials show lattice deformations and defects, for the production of preparations useful far the therapy of dentine hypersertsi-A~f '~~t~ ~T
i m...r. rvm~crwnvcr~n.rac« v-r .a-iv- v : i~~t ~ vvvvvvvvvv-~ rr~ c~a t.~a~rrot~~xt:
. I~l : H. TEL : 000~6~60 fl1 Gin. ~~: 0'~: 49 P1? .
-'i''c~-tivity and for the rernineralisa~on aF enamel and dentine.
_ fps it is known, apatites represent the rr~ait~ inorganic process of c~ici-fication c~f normal tissue (i.e. enartoel, dentine, ce~°ne~t, bone) and are found associated ~rrith oifier phosphatEC arid nan-pho,~phatic minerals in path~rlogi~ai calcifications. The main one of these compo~nnds, i.e. hydroxy~apatita or hy_ droxyiapatite ~HA~, ha ink the st~aichiam~tric formula Ca~Q(PCt~)s(dN)2 for Ca~~Pt7~ai?H), and being - in its synthe#ic ~bic~compatible) form - the apa#ite rrraterial most Snrideiy exploited at a commerciail Level for several indica#ions in d~eniistry, orthopaedy and maxilio-tacial surgery, is neYer found in a pure state ~ o in the hiola~ical tissues. This is due to the possible Esomorphaus replacements :.
~~e ~a~~, pp~,~- and C~H- ions. Tl~e calcium ion may be totally or partially replaced by a number of cations generally (but not exclusively) having oxida-tion number +2; the phosphate ion (site B} rnay be replaced by carbonate, acid phosphate, pyrophosphate, sulphate, alurninate and silicate ions, and the hydroxyl ion (site A} may be replaced by halogenide, carbonate and oxide ions.
In comparison with the value 1.67 of the stoichiometric hydroxyapatite, biological apatites have a Ca/P molar ratio co3mprised between 1.53 and 1.74 (in particular, comprised between 1.53 and 1.64 for the dental enamel, be-tween 1.62 and 1.68 for the dentine and between 1.72 and 1.80 for the bone).
In general, the oscillations in the CaIP ratio may be caused by: 1 ) lattice va-cancies; 2) ions isomorphically replaced or adsorbed on the lattice surface (for instance, the substitution of the P04s- anion with acid phosphate, which is divalent, bungs about a reduction in the calcium contents); 3) coexistence or presence of possible precursors consisting of phosphates with different CaIP
~s ratio. Among the latter, in particular, there rnay be mentioned (i-tricalcium phosphate {~i-TCP, i.e. Ca3{P04)z, an orthophosphate also known as tribasic calcium phosphate), amorphous calcium phosphate (ACP), octocalcium phos-phate (OCP, Ca$Hz(P04}6~5H20), dicalcium phosphate dehydrate (DCPD, CaHP04~2H20, also known as calcium acid phosphate, dibasic calcium phos-2o phate or dicalciurn orthophosphate). As it m~iy be deduced from the corre-sponding formulas; the Ca/P molar ratio valuEa for some of the phosphates considered are as follows:
HA Ca5{P04)3OH 1.67 (i-TCP Ca3{PO4)z 1:50 25 OCP Ca8Hz(P04)6~5H20 1.33 DCPD CaHP04~2H20 1.00 More correctly, the biological apatites may be described as non-stoichio-metric carbonatoapatites containing, in general as impurities, different ions.
For this reason, biological apatites have variable rnorphology, crystalline charac-3o teristics, chemical and phisico-chemical properiries.
Among the possible phosphates and a~patite materials, either naturally occurring or obtainable by synthesis, suitable for the production of materials for use in the odontostomatologic and biomedic fields, hydroxyapatite [Ca5(P04)30H~ has already been presented as the most widespread material.
In its structure, the phosphate and calcium ions are placed approximately according to a hexagonal prism; in the direction of elongation (crystallographic s axis c) the prism is crossed by a channel having a diameter of 3-3.5 A, hous ing any OH- groups or other possible replacing ions (e.g., fluorine and chlo rine). HA may crystallise in two forms: a monocl'ine form {spatial group P2~/b) and a hexagonal form (spatial group P63/m): In the monocline form, a binary symmetry axis is present along the axis c, vvhile in the hexagonal form the ~o symmetry axis becomes hexagonal.
Some Authors have hypothesised for the biological samples a simul-taneous presence of amorphous calcium phosphate (ACP) and of scarcely crystalline hydroxyapatite. These two phosphates would differ from each other in the intensity of the diffracted X-rays, while having the same broadening of ~5 the peaks. The same Authors hypothesised that the bone tissue contains both phases, the first one to be deposited being ACP; with time, the latter phase would undergo a transformation into microcrystalline HA according to a partial solubilisation process, with subsequent renucleation. The transformation pro-cess of ACP is apparently controlled by environmental factors (ATP, pyro-2o phosphates, Mg2+, etc.), which stabilise with their presence one of the two phases.
Also octocalcium phosphate [Ca$H2(;P04)6-5H20] {OCP) has been found in biological samples. Its crystalline structure appears to be very similar to the structure of hydroxyapatite. Actually, Ot~P may be transformed into HA
25 through a simple chemical mechanism such as the in situ hydrolysis of the already formed crystals. This kind of transformation, considered to be irre-versible, allows foreign ions to be incorporated in the crystal lattice. Such process might also be controlled by a "layer by layer" transformation, meaning that as soon as OCP is deposited in a layer of the thickness of a unit cell, this so is hydrolysed and transformed into two layers consisting of two unit cells of HA. OCP may be considered to be a mediator between the aqueous phase and the apatitic phase. The kind of product obtained (i.e. OCP or HA) depends on the relative rates of the OCP precipitation process and of the transforma-Lion thereof into HA.
As concerns the possible cation replacement in the apatite formula, although this problem has been studied in thE: literature, the only information s of some interest is that the solid solutions are structurally more ordered when the size of the replacing cation is large. It is not possible to theoretically fore-see the ability of calcium of being replaced by chemically and crystallographi-tally similar ions; in addition, also when this is the case, the extent of the iso-morphaus replacement may be partial. However, it is ascertained that the ~o preparation method has a substantial influence on the extent of the replace-ment.
In an aqueous environment and under conditions similar to the physiological ones, the Mg2* ions inhibit the hydroxyapatite precipitation and promote the formation of (i-tricalcium phosphate. Actually, when the magne-~s slum concentration exceeds 10% the simultaneous formation of ~HA and ~i-TCP occurs, the latter being the only product that precipitates when the con-centration exceeds 25%. The fact that magnesium replaces calcium in (i-TCP
is made evident by the displacement of the X-ray diffraction peaks in the pow-der diffraction spectra of the same samples.
2o However, the magnesium contents in biological apatites is very low {about 1 %), and is limited to a surface deposition. This is evidenced by the fact that during the initial dissolution stage oi' biological apatites (both bone apatite and tooth enamel) a prevailing relea;>e of magnesium ions may be observed. In the apatites with magnesium replacement, the lattice parameters 2s show a slight contraction, and the infra-red {LR.) spectrum bands are shifted towards lower frequencies, in accordance with the lower atomic mass of mag-nesium and with the different energy of the Mg-O interaction.
Strontium is present in biological apa~tites only at the impurity level, and may replace calcium, thus causing an expansion of the a and c axes. The 3o presence of this element in apatites for odontostomatological use is consid-ered to be important in connection with a possible cariostatic effect thereof (in addition to the hypothesised effect of reduction of the dentine sensitivity), and confers on the apatite a lower solubility and a higher resistance to thermal treatments.
As concerns barium, this cation does not isomorphicaily replace cal-cium in the whole concentration interval. As a matter of fact, the variation of the lattice parameters results in an expansion of the cell parameters.
As pointed out before, the basic structure of hydroxyapatite may also be substituted with anionic groups, in particular, in carbonatoapatite the car-bonate ion may replace the hydroxyl ion (site .A) or the phosphate ion (site B) or both. Although the replacement of the carbonate ion in the site B is prefer-~o ential in the biological samples, it is also possible to obtain carbonatoapatites of the type A synthetically, by means of high temperature reactions. On the other hand, ca~bonatoapatites of the type B o~r mixed type A + B are mainly obtained by precipitation from solutions.
The presence of the carbonate ion in the different sites, which is ~5 hardly detectable by X-ray diffractometry, may be evidenced through LR.
spectroscopy, since the position of the absorption bands of the carbonate ion directly depends on the occupied site. The presence of the carbonate ion in hydroxyapatite modifies the lattice dimensions: if the said ion occupies the A
site an increase in the a parameter is obtained, as a consequence of the 2o greater size of the C032- ion with respect to the OH- ion; if, on the contrary, the carbonate ion occupies the B site the same parameter undergoes a con-traction, due to the smaller O-O distance in the C032--ion with respect-to the P043- ion. In addition, it has been observed that the inclusion of the carbonate ion in apatite results in a reduction and in a diifferent morphology of the crys-25 tats, which appear to change their shape from a needle-like one to one of comparable length in the various crystal dimensions. The solubility increases as well, while the thermal stability decreases.
In fluoro- and chioroapatites the F- and CI- ions, respectively, replace the hydroxy ion; the said replacement, theoretically, may be total. Fluoroapa-3o tite is characterised by an increase in the crystal dimensions, by a decrease in the a parameter of the unit cell, by a lower solubility and by an enhanced thermal stability. The lower solubility, and therefore the higher lattice stability, of the fluoroapatites substantiates the present use of the fluoride ion in the therapy of bone affections and of dental caries.
Chloroapatite is characterised by an expansion of the a side and a contraction of the c side of the unit cell. The different lattice behaviour of chlo-s roapatite with respect to fluoroapatite derives from the remarkable difference in ionic radius between the two halogens: in l7uoroapatites the fluoride ion is placed on the senary axis located on the plane defined by the three calcium ions, while in chloroapatites the chloride ion is slightly displaced from the plane of the metal ions. This phenomenon results in the above-mentioned parameter variations of chloroapatite, while the crystallinity does not seem to be significantly affected, even if the thermal slrability decreases: It is possible to observe the presence of solid solutions t~etween fluoroapatites and hy droxyapatites and also between chloroapatites and hydroxyapatites in the whole concentration range; solid solutions may also occur befinreen fluoroapa ~5 tites and chloroapatites.
The non-stoichiometric character of biological apatites may also be caused by the presence of the acid phosphate ion HP042-; this ion is con-tained specifically in the tooth enamel, in amounts comprised between 5% and 15%, and is effective in increasing the hydroxyapatite solubility. The presence 20 of acid phosphate in biological and synthetic apatites is not easily detectable, since the carbonate ion, which is almost aiways present, overlaps the LR.
absorption bands and causes a similar variation of the cell parameters: The original presence of HP042- may be evidenced by the pyrophosphate forma-tion, obtained by heating the apatite samples between 400 a 500°C.
25 According to some specific embodiments of the invention, therefore, the M cation is chosen among the following ones: H+, Na+, Mg2+, K+, gr2+, Ba2+ and Fe2+, and preferably the x value is comprised between 0 and 2. The B anion is chosen, preferably among C032-, HP042-, HC03-, and P2074-, while the y value may be comprised, for instance, between 0 and 2. As far as so the A anion is concerned, according to a specific choice the latter is absent, the z value being equal to 0 (hydroxyapatites), while according to another specific choice the A anion is F-, with z = 2 (fluoroapatites).
The nanostructured apatites according to the invention may be pro-duced by any one of the several known methods, already in use for the pro-duction of nanocrystalline materials, such ass the synthesis methods from atomic or molecular precursors (e.g., chemical or physical vapour deposition, condensation in gas, chemical precipitation, reactions from aerosol), the methods of production from mass precursors (e.g. by mechanical attrition, by crystallisation from the amorphous state, by plhase separation), and the meth-odg borrowed from nature (i.e., biologically mirnicked systems).
The conventional deposition of layers of material by electrolytic proc-esses or by vapour condensation has been exploited in recent times to de-posit materials of nanometric dimensions with remarkable control and accu-racy. The new or improved methods inctude~, in particular, increasingly ad-vanced mono- or multi-bath systems for elecl:rodeposition and new chemical 15 or physical vapour depcssition methods, such as molecular beam epitaxy (MBE), metal-organic chemical vapour deposition (MOCVD) and chemical vapour synthesis (CVS). Such methods not only afford an accurate control on the chemistry and the thickness of the layer deposited on a nanometric scale, but they also afford, in some cases, to control the nature of the interfaces 2o within the same layers (t_.E. McCandlish, D.E:. Polk, R.W. Siegel, and B.
H.
Kear, Multicomponent Ultraflne Microstructure:;: Mater. Res. Soc. Symp. Proc.
132 (1989); G. Gumbs; S. Luryi, B. Weiss, and G.W. Wicks: -Growth, Proc-essing and Characterisation of Semiconductor Heterostructures: Mater. Res.
Soc. Symp. Proc., 326 (1994}).
25 Several new opportunities also exist in the meld of the production of nanophasic materials assembled from atomic clusters synthesised through physical and chemical methods. For instance, chemical precipitation repre-sents one of the conventional methods for synthesising ultrafine powder or colloidal suspensions that has been successifully applied in the synthesis of so nanometre-sized clusters with narrow dimensional distribution, for instance by applying the sol-gel technique or the inverse nnicelle method: Also many high-temperature gas reaction methods are presently available for the synthesis of nanometric clusters, or of nanostructured powders of bigger size (R.W. Siegel, 1991, loc: cit. ).
As far as the latter group of techniques is concerned, the synthesis of nanocrystalline materials by in sifu consolidation, under vacuum, of ultrafine particles condensed in the form of nanometre-sized gas starts when a precur-sor material, be it an element or a compound; is evaporated into a gas main-tained under low pressure, generally well below 1 atmosphere. The evapo-rated atoms loose energy as a result of the collisions with the atoms or mole-to cules of the gas, and undergo a homogeneous condensation suitable to form clusters of atoms in the highly supersaturated area close to the precursor source. In order to keep the clusters dimen:>ions small while reducing to a minimum the growth with further atoms or molecules or the coalescence among the clusters, it is necessary to rapidly remove the previously nucleated ~5 clusters from the highly supersaturated zone. Since the clusters are already suspended in the condensation gases, this may be readily obtained by pro-viding for the conditions to displace the said gias, for instance by natural con-vection or by forced circulation. The gas-suspended clusters are then con-veyed towards a collecting surface (the collection occurring by thermophore-2o sis} and are then placed in a piston-anvil device for consolidation. It is also possible to cant' out, for instance, a direct deposition of clusters as thin ~tms or filaments.
Only three basic parameters, working in connection with each other, control the atom clusters formation in the gas condensation process described 25 in the foregoing (McClandish et al., 1989, loc, cif.), namely: the rate of atoms supply to the supersaturation area wherein thE; condensation occurs, the rate of energy removal from hot atoms through the condensation medium, i.e. the gas, and (Siegel, 1991, loc. cit.) the removal rate of the previously nucleated clusters from the supersaturation area.
3o The mechanical attrition method (i.e. (lattice destabilisation) allows to produce nanostructures, rather than by cluster coalescence, through the de-composition of coarse-grained structures, caused by a severe mechanical ~CA 02338021 2001-O1-17 deformation. The nanometre-sized grains fornn a nucleus within slip bands of highly deformed precursors materials, thus transforming a coarse-grained structure into a nanophasic one. A great deformation is normally obtained by means of a high energy crushing; but it may also occur as a consequence of s surface wear phenomena (E: Hellstern, H.J. F'echt, Z. Fu and W.L. Johnson., J. Appl. Phys., 65 (1989); C.C. Koch, Nanostructured Mater., 2, 109 (1993)), or it may be obtained through other methods of introduction of high deforma-tion densities (R. Valiev, in Mechanical Properties and Deformation Behaviour of Materials Having Ultra-Fine Microstructures, M. Nastasi, D.M. Parkin, ,and ~o H: Gleiter. 303 (1993)}. In the course of the hard mechanical work on the precursors it is also possible to react different materials so as to have them form new phases and compounds.
This quite direct and relatively easy method offers a ready access to the ultrafine grain dimensions useful for the purposes of the invention, and ~5 allows to produce commercial amounts of material. The method has been used for the synthesis of the nanostructured apatite materials according to the invention that underwent the comparative experimentation described further on. The nanostructured apatite material accoirding to the invention was pro-duced starting from apatite with microcrystalliine structure through lattice de-_ 2o stabilisation in a controlled environment, under high energy, by subjecting the starting material to a high mechanical energy transfer treatment. The latter is carried out into a cylindrical reaction chamber by means of high energy im-pacts from hard balls contained within the same chamber. The kinetic energy of the balls is generated by a rotation rnovemE;nt of the chamber with respect z5 to its main axis and by a revolution movement of the same with respect to an axis parallel to the main one. The transformation of kinetic energy into me-chanical energy of lattice destabilisation occurs through impacts between the balls and the starting material. The chamber may work either in air or in inert gas or under vacuum, down to a pressure value of 10-~ torr, or with liquids 30 (alcohol, ethers, oils and other organic molecules).
The above method reduces the crystallites dimension through subse-quent introduction of lattice defects (which may be evaluated by means of X-ray diffraction techniques). In particular, the n~anoapatite material obtained by the disclosed synthesis method and employed in the applications reported herein shows an average dimension of the crystallites of about 15 nm, with an average strain ranged between 10-5 and 10-2.
s The apatite-based nanocrystalline products according to the present invention represent a material that simulates the dentine composition and is perfectly compatible, both biologically and structurally, with the dental tissue.
The material is able to efficiently become stably integrated with the dentine, thus making it totallx impermeable. The dimensional features, the properties of surface activity and the defective contents of the nanoapatites, preferably obtained according to the previously disclosed method, allow to easily obtain both the mechanical filling of the tubules and the fixing reaction with the tubule surface {i.e. remineralisation). Therefore, the clentine sensitivity resulting from the hydraulic conductivity through the tubule structure of dentine is practically removed. As noted in the foregoing, the said permeability is a critical factor in the dentinal pain stimulation theory, as the presence of exposed and open tubules causes, when suitable external stimulii are present, the movement of dentinal fluid, perceived at the neural structure level as a pain stimulus.
According a preferred embodiment of the invention, the nanocrystal-20 line apatite materials are protected from acid attack by subjecting them to a treatment with protective aqueous solutions containing tartaric acid andlor its - salts, such as; e.g., aqueous solutions contaiining potassium sodium tartrate {or Seignette's salt, or Rochelle's salt, NaC>OC(CHOH)2COOK~4H20) and hydrous calcium acetate {Ca{CH3C00)2~H20;~, or, in the alternative, with a 2s solution containing tartaric acid (HOOC(CHOH~ COOH). Preferably, a 0.1-1.0 M solutioh of potassium sodium tartrate and a 0.1-1:0 M solution of hydrous calcium acetate are used in a sequence, by dipping therein the material ac-cording to the invention, preferably at 37°C, for periods of time comprised between 5 and 30 minutes. Specifically, the rjanoapatite is immersed in the 3o first solution and kept therein for 5 minutes, then it is withdrawn from the first solution and immediately immersed in the second solution for 20-30 minutes.
The material can also be individually treated with one of the following ii K1,1.. 1~U:~ ~ ~.Yt1-hll~tWCaIt:IV U4 ::?'?- lU- U : 'T : ij.. j ..
UIIUUUt)Ui3UU-> +4a t3J '.,~.~~~bti:~: # 1~
DR : t~l. TEL t SflflC~00i~3~ 01 Gen. 2~0t 07: 50 Flew agents: rncno-, bi-, tri-, tetra-, polycarba~cyiated caiciurn gluconate in aqueous solution at a co~aer~tration of 0.0~ _5°~ by v~eiyhtt or in aE:cohoiic or hydroatco-hoiic solution at a r"ancentratlon 'sn the range from O.t3l °~ and 15~k by weight;
or with art acetic andfor rrialic a~nd~or hyalt~ronic solution of ohitosac~ at a ccsn-s centration in the rarsge from 5°~ to 2(3°~ by vrei~~ht; or with a solution of human, bovir~, swine, rat or turi~ey tendorx collagen, either isotonic or not, at a con-centration in the range from ~.5a/a to 5°~o by weight. The said treatments result in a protection of the r~anostructure~i materi~a from acid environments. The said mater;at, however, rnay also be used vtrith~out any further treatment.
~ o the invention Rather concerns compo:~tiar~ for the #herapy of dentine hypersensitivity and for the r~e~roinsr~eiisafion of enamel and dertti~
(~mprisirtg the apatite-Eased nanostruclured materials desait5e~d in the far~egoing, toge~er-w~h further possible ingredients and exclpients of the ;same kind as those used in p~aa-rations frx dental h3rc~ier~ and for the therapy of the oral cavity. The oampositions, ~ s that are pre~r ably in the fame of ~too~te, haste, get, suspension or solution, preferably an from ~.5°!o to 50°k by weight of nanocrystaliine ratite rrtateriai, either treated with protect~re agents or not Fur~~ preferred flees of the cornpo- .
sitions according to the inventjon, with particular reference to oral fonnutations in the get form, are ' Ced in the fuhher dependent dairr~s.
2o Some specific embodiments of the irwention are described below for merely itluatrative purposes, together with the results of tine experimental studies carried out on the proposed rranvstr«cfured tarQducics, ir~ciuding com-parati~re tests with other non-nanocrystalline <~patite materials.
EXAMi'L~ 'E
A rnicracrystaliine carbonate-apatite materiat, nor.-stoiahte~rt7etric as regards the hydroxy ion, was subjected to a lattice destabilisation treatment in a controlled environment, under high energyi, by using the r~eact~on charrrber r~escribed in the foregoing. The resulting pn~duct ~nanospatite) is character iced by average crystallite sues of 15-2C3 nrn anct by an average rniorostrain so content comprised between '! ~~' and 1 Ct's.
A portion of the nanocrystatline ap~~tite thus obtained which will be referred to in the fooltowing as nanoapatite 't or r~ano 't ) has also been sub-~~~ 'r~D ..: . ~
jected to treatment with tartrate in order to increase its resistance to acid at-tack in the conditions of use in the oral cavii;y. To that aim, the nanoapatite was treated with a 0.1 M aqueous solution of potassium sodium tartrate (Sei-gnette's salt, Carlo Erba, Milano) at 37°C for 5~ minutes, and then with a 0.1 M
solution of hydrous calcium acetate (Carlo Erba, Miiano) at 37°C for 20 min-utes.
An apatite material of the same nature and composition as the mate-rial of Example 1 was subjected to a similar !lattice destabilisation treatment, with a different value of the energetic content transferred. The resulting nanoapatite was characterised by average crystallite dimensions of 10-14 nm and by an average microstrain content compri:>ed between 5~10' and 10'x.
Also in this case, a portion of the nano~crystalline apatite thus obtained (i.e. nanoapatite 2 or nano 2) was treated with potassium sodium tartrate and ~5 hydrous calcium acetate, according to the same procedure of Example 1.
~ Dentine permeability test The effectiveness of the nanocrystailine apatite products according to the invention in the treatment of dentine hypersensitivity was evaluated in 2o terms of reduction of the hydraulic conductance within the dentine tubules, according to a well established protocol (Pas~hley, 1990, loc. cft.), in agree-ment with the international literature. In ordear to carry out such test, sound human molars have been used, extracted for orthodontic reasons from young patients, in order to avoid the problem of sclE;rotic dentine. Each crown was 25 properly separated from the root and cut in order to obtain a crown segment deprived of the occlusal enamel. After removing the pulp tissue, the crown segment was fixed by means of adhesive onto a Plexiglas base, with the flat surface of occlusal dentine facing upwards. The base was crossed through its entire thickness by a tubular stainless steel sE;gment, projecting into the pulp 3o cavity in order to provide the hydraulic connection, below the Plexiglas base, with the hydraulic conductance measuring device. The latter was made of a simple hydrodynamic device consisting of a set of capillary tubes filled with deionised water and connected through the tuibular stainless steel segment to the pulp cavity. The passage of water from the pulp cavity to the occlusal surface through the dentine was evidenced by the displacement of an air bubble in a graduated microcapillary tube located in the hydrodynamic sys-s ~ tem.
The tests reported below where carried out; by means of the de-scribed equipment, by applying on the exposed dentine surface a car-boxymethyl cellulose-based gel, to which the single active ingredients under test were added in tum. Each batch of gehwas obtained by dissolving fi g of ~.o carboxymethyl cellulose at 50°C in an aqueous solution containing 0.2% by weight of paraben, and-stirring the solution until a transparent gel, of the right consistency, was obtained. The various products under test were mixed to 3 ml aliquots of the gel thus produced, according to the following scheme:
1. control, consisting of the only gel vehicle;
15 2. commercial microcrystalline hydroxyapatite (Merck, Darmstadt, Germany, Art. 2196);
3. commercial microcrystalline hydroxyapatite treated with potassium sodium tartrate and hydrous calcium acetate as described in Example 1;
4. nanoapatite 1, produced according to Example 1;
20 5. nanoapatite 1 treated with potassium sodium tartrate and hydrous calcium acetate according to Example 1;
- 6. nanoapatite 2, produced according to Example 2;
7. nanoapatite 2 treated with potassium sodiuim tartrate and hydrous calcium acetate as described in Example 1.
25 According to the well established procedure referred to in the forego-ing, for each test the following passages were carried out:
~ Formation of a smear layer by rubbing with abrasive paper under manual pressure, followed by washing in deionised water.
~ Treatment with 0.5 M EDTA (ethylene diammine tetraacetic acid, Sigma, 3o St. Louis, USA) at pH 7.4 for 5 minutes. The permeability was measured after leaving to stand for 2 minutes and subEsequently washing the sample.
The value so obtained was taken as a reference for the following tests, by associating it to a permeability of 100%.
Treatment with the control gel or the gel containing the apatite under test (either treated or non treated} by brushing the tooth for 3 minutes. The said time has been chosen with reference to the correct brushing time in the s normal toothbrushing operation. The tooth was painted rather than brushed, in order to avoid forming a smear layer, which would interfere with the evaluation of the product activity.
~ Etching with 37 wt. % ortophosphoric acid (PJlerck, Darmstadt} for 1 minute, and washing. The permeability was evaluated after leaving to stand for 1 a minute.
The permeability tests were pertormed seven, times for each of the set times {30, 60, 120 seconds) after treatment wiith each single gel, and repeat-ing each stage of the above procedure.
The results thus obtained are presented in the following Table in re ~s sped of all of the procedural steps. In order to f;vidence the behaviour of each gel in the presence of acid attack, the data corresponding to the evaluation at 60 minutes after the gel application and after treatment with ortophosphoric acid are also presented in the histogram of the <~ttached Figure. ~' WO 00/03747 _2~_ PCT/IT99/00224 0 ~ ~ N
N ~ O N 00 .
O h M
d' M M M
r> ~
O M M O ~ ~ r C i' D
I ~ M O M
~
N
r' t d' ' ~t' .~,, tB
L M ~ M O ~ ~ ~ , ' C C7) e ' D -M ~ j o ~ C ~ M
J
_ N N ~ ~ ~ ~
O O t O
.
~ N M
C
l~d d M C~ M
' "
, O
UJ
a U
~ O ~ ~ O
C M N
O
("" ~ ~ ' M M M M w-~' 00II d .
~
O Cs c ~
L
M N O ~ ~ ~ 0 ~. ~ 0 N
a ~ ~ N , LJ! CD ~ ' d ~ M
d' ' O
' 't o o o o o a o o 0 0 z mu ~ o o o o a~
-- - --~ , ~ ~ r.. ~
.~
3 a~
ina ~ r' c v ~ o M
~ c ~-oo~ ~ rf Sri ~ ai cDcD cD co cD so cfl J !
O JJ
... ~ N ~
~ ~ a M ~ ~ ~ ~
~ M A ~ N
C C C C
D D D D
L
m a C
M O ~ N
l d: M l~ r o ~ o ~, ~ ~ ~ ~- N N .C
~ _ N ~ ~ ~ ~ cUC
~
V
O
~ 0 0 U
I= Z Z Z Z Z Z
From the observation of the foregoing table the following conclusions may be drawn, which are even more evident from the enclosed histogram: no positive result was obtained with the control (c;arboxymethyl cellulose gel), as the dentine was extremely permeable, and particularly susceptible to acid attack, so much so that upon treatment with H3P04 the permeability values are above 100% (see Figure).
The use of commercial microcrystallline hydroxyapatite may bring about a partial occlusion of the dentine tubulE;s, with reduced permeability in comparison with the smear layer formation step. However, after the action of H3P04 no detectable resistance is noted. Some resistance is present, on the other hand, if microcrystalline hydroxyapatite is treated with the Seignette's salt and calcium acetate solutions. The behaviour before and after acid attack, with or without the protective treatment, is evident from the enclosed histo-gram.
~5 With the use of -nanoapatites 1 and 2 the dentine permeability is greatly reduced, to the point that the permeability falls from 100% after treat-ment with EDTA to about 40% after reatmE;nt with the nanoapatites, and further improves up to 120 seconds. In this case, even the acid attack does not result in any appreciable negative effect" this being certainly the most 20 interesting data.
The effectiveness of the treatment with nanocrystalline apatite ac-cording to the invention is even more-evident when nanoapatites treated with Seignette's salt and calcium acetate are used. These not only produce a re-markable reduction in the dentine permeability in the absence of an acid at-25 tack, but, most remarkably, afford an even more considerable reduction after the final acid attack by H3P04, with permeability values not exceeding about 35% of the value after treatment with EDTA.
Although the statistic analysis did not evidence any significant differ-ence between nanoapatites 1 and 2, nanoap~atite 2 gave a lower standard 30 deviation in the measurements, and therefore a greater reproducibility in the results.
From the experimental results presented in the foregoing it will be iI.
twV.Vt)tV:~t'A-A'lU~.~!C'.H~.'~i 04 ~'?~-10- 0 : ~:~I ~ UUUUUUUt?UV-~ +ga ts~ -:a~~~tr~a:W ~r ht. Ta. : fl00~006Q~ 01 G ~. e''.~i 07: 50 P14 .- 28 -appreciated that tl~e r~anastr~tctur2d apatite materials according tc~ the inven-tion can be vaiiclly praposed as biot~mpatibie matariais having a marked and prolonged actian in reducing the hydraulic ccrrduGtance within the dentine tui'uies, ~d suitable to become stably arid deeply integrated Era the dentine $ tissue. Accordingly, tt~e said rnatetials may advarttageousiy be ert~plo~red, either as such or included in powder, taot~apaste, paste, gel, solul~orrs, mruth-wash, suspensions, tabltrt, capsule, resin or c:e:rnent c~rrEpositions, in prepara-tions for the protection of dentine; son tt~e therapy of dentine hypersensitivity, for the remineratisation of enamel, dentine arnd denial tissues, for the dosure ~a oaf dentine tubules or the reduction of their functional diameter, fior ttie protec-lion t~f dental pulp ark as sealants for enamel .and dentine.
'~"r~e present invantian has been disclosed with particular reference to some specific era~t~dirnents thereof, hut it should be understood that rnodi~-cations and ,~,hanges may be unade by the persons skilled in the art without ~ 5 departing from the scope t~F tl~e invention as defined in the appended dairns.
25 According to the well established procedure referred to in the forego-ing, for each test the following passages were carried out:
~ Formation of a smear layer by rubbing with abrasive paper under manual pressure, followed by washing in deionised water.
~ Treatment with 0.5 M EDTA (ethylene diammine tetraacetic acid, Sigma, 3o St. Louis, USA) at pH 7.4 for 5 minutes. The permeability was measured after leaving to stand for 2 minutes and subEsequently washing the sample.
The value so obtained was taken as a reference for the following tests, by associating it to a permeability of 100%.
Treatment with the control gel or the gel containing the apatite under test (either treated or non treated} by brushing the tooth for 3 minutes. The said time has been chosen with reference to the correct brushing time in the s normal toothbrushing operation. The tooth was painted rather than brushed, in order to avoid forming a smear layer, which would interfere with the evaluation of the product activity.
~ Etching with 37 wt. % ortophosphoric acid (PJlerck, Darmstadt} for 1 minute, and washing. The permeability was evaluated after leaving to stand for 1 a minute.
The permeability tests were pertormed seven, times for each of the set times {30, 60, 120 seconds) after treatment wiith each single gel, and repeat-ing each stage of the above procedure.
The results thus obtained are presented in the following Table in re ~s sped of all of the procedural steps. In order to f;vidence the behaviour of each gel in the presence of acid attack, the data corresponding to the evaluation at 60 minutes after the gel application and after treatment with ortophosphoric acid are also presented in the histogram of the <~ttached Figure. ~' WO 00/03747 _2~_ PCT/IT99/00224 0 ~ ~ N
N ~ O N 00 .
O h M
d' M M M
r> ~
O M M O ~ ~ r C i' D
I ~ M O M
~
N
r' t d' ' ~t' .~,, tB
L M ~ M O ~ ~ ~ , ' C C7) e ' D -M ~ j o ~ C ~ M
J
_ N N ~ ~ ~ ~
O O t O
.
~ N M
C
l~d d M C~ M
' "
, O
UJ
a U
~ O ~ ~ O
C M N
O
("" ~ ~ ' M M M M w-~' 00II d .
~
O Cs c ~
L
M N O ~ ~ ~ 0 ~. ~ 0 N
a ~ ~ N , LJ! CD ~ ' d ~ M
d' ' O
' 't o o o o o a o o 0 0 z mu ~ o o o o a~
-- - --~ , ~ ~ r.. ~
.~
3 a~
ina ~ r' c v ~ o M
~ c ~-oo~ ~ rf Sri ~ ai cDcD cD co cD so cfl J !
O JJ
... ~ N ~
~ ~ a M ~ ~ ~ ~
~ M A ~ N
C C C C
D D D D
L
m a C
M O ~ N
l d: M l~ r o ~ o ~, ~ ~ ~ ~- N N .C
~ _ N ~ ~ ~ ~ cUC
~
V
O
~ 0 0 U
I= Z Z Z Z Z Z
From the observation of the foregoing table the following conclusions may be drawn, which are even more evident from the enclosed histogram: no positive result was obtained with the control (c;arboxymethyl cellulose gel), as the dentine was extremely permeable, and particularly susceptible to acid attack, so much so that upon treatment with H3P04 the permeability values are above 100% (see Figure).
The use of commercial microcrystallline hydroxyapatite may bring about a partial occlusion of the dentine tubulE;s, with reduced permeability in comparison with the smear layer formation step. However, after the action of H3P04 no detectable resistance is noted. Some resistance is present, on the other hand, if microcrystalline hydroxyapatite is treated with the Seignette's salt and calcium acetate solutions. The behaviour before and after acid attack, with or without the protective treatment, is evident from the enclosed histo-gram.
~5 With the use of -nanoapatites 1 and 2 the dentine permeability is greatly reduced, to the point that the permeability falls from 100% after treat-ment with EDTA to about 40% after reatmE;nt with the nanoapatites, and further improves up to 120 seconds. In this case, even the acid attack does not result in any appreciable negative effect" this being certainly the most 20 interesting data.
The effectiveness of the treatment with nanocrystalline apatite ac-cording to the invention is even more-evident when nanoapatites treated with Seignette's salt and calcium acetate are used. These not only produce a re-markable reduction in the dentine permeability in the absence of an acid at-25 tack, but, most remarkably, afford an even more considerable reduction after the final acid attack by H3P04, with permeability values not exceeding about 35% of the value after treatment with EDTA.
Although the statistic analysis did not evidence any significant differ-ence between nanoapatites 1 and 2, nanoap~atite 2 gave a lower standard 30 deviation in the measurements, and therefore a greater reproducibility in the results.
From the experimental results presented in the foregoing it will be iI.
twV.Vt)tV:~t'A-A'lU~.~!C'.H~.'~i 04 ~'?~-10- 0 : ~:~I ~ UUUUUUUt?UV-~ +ga ts~ -:a~~~tr~a:W ~r ht. Ta. : fl00~006Q~ 01 G ~. e''.~i 07: 50 P14 .- 28 -appreciated that tl~e r~anastr~tctur2d apatite materials according tc~ the inven-tion can be vaiiclly praposed as biot~mpatibie matariais having a marked and prolonged actian in reducing the hydraulic ccrrduGtance within the dentine tui'uies, ~d suitable to become stably arid deeply integrated Era the dentine $ tissue. Accordingly, tt~e said rnatetials may advarttageousiy be ert~plo~red, either as such or included in powder, taot~apaste, paste, gel, solul~orrs, mruth-wash, suspensions, tabltrt, capsule, resin or c:e:rnent c~rrEpositions, in prepara-tions for the protection of dentine; son tt~e therapy of dentine hypersensitivity, for the remineratisation of enamel, dentine arnd denial tissues, for the dosure ~a oaf dentine tubules or the reduction of their functional diameter, fior ttie protec-lion t~f dental pulp ark as sealants for enamel .and dentine.
'~"r~e present invantian has been disclosed with particular reference to some specific era~t~dirnents thereof, hut it should be understood that rnodi~-cations and ,~,hanges may be unade by the persons skilled in the art without ~ 5 departing from the scope t~F tl~e invention as defined in the appended dairns.
Claims (27)
1. Use of an apatite-based nanostructure material of the general formula:
Ca10-x M x(PO4)6-y B y A z(OH)2-z wherein M is a cation different from Ca2+, B is an anion different from PO4 3-, A
is chosen from the group consisting of O2-, CO3 2-, F- and Cl-, x is a number from 0 to 9, y is a number from 0 to 5, z is a number from 0 to 2, wherein the said numbers may also be fractional, with the proviso that the sum of the charges of the Ca and M cations is equal to the sum of the charges of the PO4 3-, B, A, and OH- anions, wherein the average size of the crystallites of said nanostructured material is comprises between 1 and 50 nm, for the production of preparations for the therapy of dentine hypersensitivity and for the remineralisation of enamel and dentine.
Ca10-x M x(PO4)6-y B y A z(OH)2-z wherein M is a cation different from Ca2+, B is an anion different from PO4 3-, A
is chosen from the group consisting of O2-, CO3 2-, F- and Cl-, x is a number from 0 to 9, y is a number from 0 to 5, z is a number from 0 to 2, wherein the said numbers may also be fractional, with the proviso that the sum of the charges of the Ca and M cations is equal to the sum of the charges of the PO4 3-, B, A, and OH- anions, wherein the average size of the crystallites of said nanostructured material is comprises between 1 and 50 nm, for the production of preparations for the therapy of dentine hypersensitivity and for the remineralisation of enamel and dentine.
2. Use according to claim 1, wherein the said nanostructured material shows lattice deformations and/or defects.
3. Use of an apatite-based nanostructured material of the general formula:
Ca10-x M x(PO4)6-y B y A z(OH)2-z wherein M is a cation different from Ca2+, B is an anion different from PO4 3-, A
is chosen from the group consisting of O2-, CO3 2-, F- and Cl-, x is a number from 0 to 9, y is a number from 0 to 5, z is a number from 0 to 2, wherein the said numbers may also be fractional, with the proviso that the sum of the charges of the Ca and M cations is equal to the sum of the charges of the PO4 3-, B, A, and OH- anions, wherein the average size of the crystallites of said nanostructured material is comprises between 0.5 and 200 nm and said nanostructured materials show lattice deformations and defects, for the production of preparations useful for the therapy of dentine hypersensi-tivity and for the remineralisation of enamel and dentine.
Ca10-x M x(PO4)6-y B y A z(OH)2-z wherein M is a cation different from Ca2+, B is an anion different from PO4 3-, A
is chosen from the group consisting of O2-, CO3 2-, F- and Cl-, x is a number from 0 to 9, y is a number from 0 to 5, z is a number from 0 to 2, wherein the said numbers may also be fractional, with the proviso that the sum of the charges of the Ca and M cations is equal to the sum of the charges of the PO4 3-, B, A, and OH- anions, wherein the average size of the crystallites of said nanostructured material is comprises between 0.5 and 200 nm and said nanostructured materials show lattice deformations and defects, for the production of preparations useful for the therapy of dentine hypersensi-tivity and for the remineralisation of enamel and dentine.
4. Use according to claims 1 or 3 wherein the M cation is chosen from the group consisting of: H+, Na+, Mg2+, K+, Sr2+, Ba2+ and Fe2+.
5. Use according to any one of claims 1-4 wherein x is comprises between 0 and 2.
6. Use according to any one of claims 1-5 wherein the B anion is cho-sen from the group consisting of: Co3 2-, HPO4 2-, HCO3-, and P2O~ 4-.
7. Use according to any one of claims 1-6, wherein y is comprised between 0 and 2.
8. Use according to claim 1, wherien said material is hydroxyapatite, x, y and z being are equal to 0.
9. Use according to claim 1, wherein said material is a fluoroapatites, x and y being equal to 0, and the A anion being F-, with z = 2.
10. Use according to any one of claims 1-9, wherien the said prepara-tions for odontostomaatologic applications are powder, paste, gel, solutions, moutwash, suspenstions, tablet, capsule, resin or cement compositions for the protection fo the hard dental tissues, the therapy of dentine hypersensitiv-ity, the remineralisation of enamel, dentine and dental tissues, the closure of dentine tubules or the reduction of their functional diameter and/or for the protection of dental pulp and as sealants for enamel and dentine.
11. Use according to any one of claims 1-10, wherein the said nanos-stuctured apatite materials are treated, in the said production, with protective aqueous solutions containing tartaric acid and/or its salts.
12. Use according to claim 11, wherein a first solution of 0.1-1.0 M
potassium sodium tartrate and a second solution of 0.1-1.0 M hydrous calcium acetate are used in a sequence.
potassium sodium tartrate and a second solution of 0.1-1.0 M hydrous calcium acetate are used in a sequence.
13. Use according to claim 12, wherein the said nanostructured apa-tite material is immersed in the first solution, at 37°C, and kept therein for 5 minutes, then it is withdrawn from the said first solution and immediately im-mersed in the second solution, at 37°C, and kept therein for 20-30 minutes.
14. Use according to any one of claims 1-10, wherein the said nanos-tructured apatite materials are treated, in the said production, with protective aqueous solutions containing mono-, bi, tri, tetra- or poycarboxylated cal-cium gluconate at a concentration of 0.01-5% by weight, or in alcoholic or hydroalcoholic solution at a concentration in the range fresh 0.01 to to 15%
by weight.
by weight.
15. Use according to any one of claims 1-10, wherein the said nanos-tructured apatite materials are treated, in the said production, with a protective acetic and/or malic and/or hyaluronic solution of chitosan at a concentration in the range from 5% to 20% by weight.
16. Use according to any one of claims 1-10, wherein the said nanos-tructured apatite materials are treated, in the said production, with a protective aqueous solution of human, bovine, swine, rat or turkey tendon collagen, either isotonic or not, at a concentration in the range from 0.5% to 5% by weight.
17. A composition for the therapy of dentine hypersensitivity and for the remineralisation of enamel and dentine comprising an apatite-based na-nostructured material as defined in claim 1.
18. A composition for the therapy of dentine hypersensitivity and for the remineralisation of enamel and dentine comprising an apatite-based na-nostructured material as defined in claim 3.
19. The composition according to claims 17 or 18, wherein the said apatite-based nanostructured material is hydroxyapatite.
20. A composition according to any one of claims 17-19 in the form of a powder, toothpaste, paste, gel, solution, mouthwash, suspension, tablet, capsule, resin or cement.
21. The composition according to claim 20 in the form of a paste, a gel, or a suspension, containing from 0.5% to 50% by weight of the said apatite-based nanostructured material.
22. A composition according to claim 21 in the form of a gel, wherein the said gel contains a mixture of polyacrylic acid and/or derivatives thereof and polyethylene glycol, or a mixture of polymethacrylic acid and/or deriva-tives thereof and polyethylene glycol, or a mixture of different polyethylene glycols.
23. The composition according to claim 22, wherein the said gel also contains glycerol.
24. A gel composition according to claims 22 or 23, wherein the said apatite-based nanostructured material is contained into polyethylene glycol microspheres.
25. A composition according to claim 21 in the form of a gel, wherein the said gel contains one or more of the following gel-forming ingredients:
carboxymethyl cellulose, hydroxymethyl cellulose, optionally substituted chito-san.
carboxymethyl cellulose, hydroxymethyl cellulose, optionally substituted chito-san.
26. A composition according to claim 21 in the form of a gel, wherein the said gel is a hydrogel obtained from hydrophylic polymers of the polyvinyl or polysaccharide type, mixed with glycerol and/or polyethylene glycol.
27. A composition according to any one of claims 17-26, wherein the said nanostructured apatite material is protected by treatment with aqueous solutions containing tartaric acid and/or its salts, or with aqueous, alcoholic or hydroalcoholic rotations containing mono-, bi-, tri-, tetra- ,or polycarboxylated calcium gluconate, or with acetic and/or malic and/or hyaluronic solutions of chitosan, or with aqueous solutions of human, bovine, swine, rat or turkey tendon collagen.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98RM000476A IT1299563B1 (en) | 1998-07-17 | 1998-07-17 | ODONTOSTOMATOLOGICAL USE OF NANOSTRUCTURED APATITIC BASED MATERIALS |
| ITRM98A000476 | 1998-07-17 | ||
| PCT/IT1999/000224 WO2000003747A2 (en) | 1998-07-17 | 1999-07-16 | Odontostomatologic use of apatite-based nanostructured materials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2338021A1 true CA2338021A1 (en) | 2000-01-27 |
Family
ID=11406050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002338021A Abandoned CA2338021A1 (en) | 1998-07-17 | 1999-07-16 | Odontostomatologic use of apatite-based nanostructured materials |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1098623A2 (en) |
| AU (1) | AU5191999A (en) |
| CA (1) | CA2338021A1 (en) |
| IT (1) | IT1299563B1 (en) |
| WO (1) | WO2000003747A2 (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19930335A1 (en) * | 1999-07-02 | 2001-01-18 | Henkel Kgaa | Composite materials made from calcium compounds and protein components |
| CN1106861C (en) | 2000-05-19 | 2003-04-30 | 清华大学 | Preparation method of nanometer phase calcium-phosphorus salt/collagen/polylactic acid bone composite material |
| DE10028975B4 (en) * | 2000-06-16 | 2005-06-30 | Henkel Kgaa | Compositions for the treatment of tooth and / or bone tissue |
| JP2004511320A (en) | 2000-10-16 | 2004-04-15 | ユニバーシテイ・オブ・サウス・カロライナ | Biocompatible cement containing reactive calcium phosphate nanoparticles and methods of making and using said cement |
| DE10063945A1 (en) * | 2000-12-20 | 2002-07-04 | Henkel Kgaa | Remineralizing dental adhesive film |
| US6921544B2 (en) | 2001-03-06 | 2005-07-26 | Rutgers, The State University | Magnesium-substituted hydroxyapatites |
| US20040101494A1 (en) | 2002-11-26 | 2004-05-27 | Scott Douglas Craig | Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
| US7090721B2 (en) | 2004-05-17 | 2006-08-15 | 3M Innovative Properties Company | Use of nanoparticles to adjust refractive index of dental compositions |
| US7156911B2 (en) | 2004-05-17 | 2007-01-02 | 3M Innovative Properties Company | Dental compositions containing nanofillers and related methods |
| US7090722B2 (en) | 2004-05-17 | 2006-08-15 | 3M Innovative Properties Company | Acid-reactive dental fillers, compositions, and methods |
| US7649029B2 (en) | 2004-05-17 | 2010-01-19 | 3M Innovative Properties Company | Dental compositions containing nanozirconia fillers |
| DE102004025030A1 (en) * | 2004-05-18 | 2005-12-15 | S&C Polymer Silicon- und Composite-Spezialitäten GmbH | Nano-apatite fillers containing curable restorative materials |
| WO2006083418A2 (en) | 2005-01-04 | 2006-08-10 | Rutgers, The State University | Hydroxyapatite with controllable size and morphology |
| WO2011053598A1 (en) | 2009-10-26 | 2011-05-05 | Rutgers, The State University Of New Jersey | Hydroxyapatite with controllable size and morphology |
| DE102005027813A1 (en) * | 2005-06-15 | 2006-12-28 | Henkel Kgaa | Remineralizing oral and dental care and cleaning products |
| US8287914B2 (en) | 2006-01-12 | 2012-10-16 | Rutgers, The State University Of New Jersey | Biomimetic hydroxyapatite synthesis |
| SI2029480T1 (en) | 2006-05-30 | 2017-08-31 | Coswell S.P.A. | Biologicallly active nanoparticles of a carbonate-substituted hydroxyapatite, process for their preparation and compositions incorporating the same |
| WO2010106668A1 (en) * | 2009-03-19 | 2010-09-23 | サウスコーストデンタル株式会社 | Tooth surface repairing material |
| HUE035706T2 (en) | 2011-05-26 | 2018-05-28 | Coswell Spa | Dental care products comprising carbonate-substituted fluoro-hydroxyapatite particles |
| WO2013068020A1 (en) | 2011-11-08 | 2013-05-16 | Coswell S.P.A. | Dental care products containing biomimetic hydroxyapatite particles having a lactoferrin-functionalized surface |
| EP2591825A1 (en) * | 2011-11-08 | 2013-05-15 | PeGoMa B.V. | Composition for the treatment of teeth, and use |
| GB201202341D0 (en) * | 2012-02-10 | 2012-03-28 | Periproducts Ltd | Multicomponent oral care compostion |
| US20150238399A1 (en) | 2012-08-13 | 2015-08-27 | Matthew Scott Spaid | Tooth whitening composition |
| WO2015046491A1 (en) * | 2013-09-30 | 2015-04-02 | クラレノリタケデンタル株式会社 | One-component-type dentinal tubule sealant |
| ITMI20132003A1 (en) | 2013-11-29 | 2015-05-30 | Perfetti Van Melle Spa | CONFETTER PRODUCTS WITH CALCIUM PHOSPHATE |
| US20230190586A1 (en) * | 2016-04-14 | 2023-06-22 | M B Lloyd Limited | Dental formulation for the treatment of tooth sensitivity |
| RU2627624C1 (en) * | 2016-10-06 | 2017-08-09 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) | Means for teeth hard tissue remineralization |
| WO2020138422A1 (en) | 2018-12-27 | 2020-07-02 | シライシ カルシウム(シンガポール) プライベート リミテッド | Hydroxyapatite particulate |
| CN116251230B (en) * | 2023-01-30 | 2024-07-16 | 重庆大学 | Preparation method of biomimetic mineralized enamel for constructing unstable amorphous calcium phosphate clusters by atomization method |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0323632B1 (en) * | 1987-12-28 | 1992-07-15 | Asahi Kogaku Kogyo Kabushiki Kaisha | Composition for forming calcium phosphate type setting material and process for producing setting material |
| IT1271874B (en) * | 1994-03-07 | 1997-06-09 | Massimo Minozzi | ADDITION OF HYDROXYAPATITE, CA10 (PO4) 6 (OH) 2, ULTRAMICRONIZED, HAUM, DIAMETER OF MICROCRYSTALS: OR, 2 - 1, OR MICRON, RANGE 70% TO THE VARIOUS TYPES OF CANAL CONCRETE FOR THE FINAL FILLING OF THE ROOT CANALS OF THE TOOTH . |
| JP4040705B2 (en) * | 1996-01-24 | 2008-01-30 | 株式会社サンギ | Oral composition |
| IT1288038B1 (en) * | 1996-04-30 | 1998-09-10 | Flametal S P A | PROCEDURE FOR THE PREPARATION OF HYDROXYAPATITE COATINGS |
| DE59711025D1 (en) * | 1996-09-30 | 2003-12-24 | Degudent Gmbh | Polymerizable dental material and use of apatite fillers in the dental material |
| AU742748B2 (en) * | 1996-10-16 | 2002-01-10 | Etex Corporation | Method of preparing a poorly crystalline calcium phosphate and methods of its use |
-
1998
- 1998-07-17 IT IT98RM000476A patent/IT1299563B1/en active IP Right Grant
-
1999
- 1999-07-16 WO PCT/IT1999/000224 patent/WO2000003747A2/en not_active Ceased
- 1999-07-16 AU AU51919/99A patent/AU5191999A/en not_active Abandoned
- 1999-07-16 EP EP99936957A patent/EP1098623A2/en not_active Withdrawn
- 1999-07-16 CA CA002338021A patent/CA2338021A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000003747A3 (en) | 2000-05-11 |
| ITRM980476A1 (en) | 2000-01-17 |
| WO2000003747A2 (en) | 2000-01-27 |
| IT1299563B1 (en) | 2000-03-16 |
| AU5191999A (en) | 2000-02-07 |
| EP1098623A2 (en) | 2001-05-16 |
| ITRM980476A0 (en) | 1998-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2338021A1 (en) | Odontostomatologic use of apatite-based nanostructured materials | |
| Suge et al. | Effects of fluoride on the calcium phosphate precipitation method for dentinal tubule occlusion | |
| US4518430A (en) | Dental resptorative cement pastes | |
| USRE33221E (en) | Dental restorative cement pastes | |
| KR101258976B1 (en) | Biologically active nanoparticles of a carbonate-substituted hydroxyapatite, process for their preparation and compositions incorporating the same | |
| EP2425843B1 (en) | Dentin mineralizing agent for use in the treatment of hyperesthesia | |
| US6056930A (en) | Methods and compositions for mineralizing and fluoridating calcified tissues | |
| Ishikawa et al. | Occlusion of dentinal tubules with calcium phosphate using acidic calcium phosphate solution followed by neutralization | |
| Lee et al. | In vitro study of dentinal tubule occlusion with sol-gel DP-bioglass for treatment of dentin hypersensitivity | |
| CN104254336A (en) | Multicomponent oral care composition | |
| US6000341A (en) | Methods and composition for mineralizing and fluoridating calcified tissues | |
| US9005587B2 (en) | Anti-bacterial and mineralizing calcium phosphate compositions | |
| EP3723699A1 (en) | Novel composition | |
| Saffarpour et al. | Efficacy of modified bioactive glass for dentin remineralization and obstruction of dentinal tubules | |
| Seyedlar et al. | Synthesis of plate-like β-tricalcium phosphate nanoparticles and their efficiency in remineralization of incipient enamel caries | |
| EP3473235A1 (en) | Composition of materials for tooth remineralisation | |
| Omran et al. | Assessment of remineralizing effect of bioactive glass based toothpastes: An in-vitro comparative study | |
| US12383474B2 (en) | Stabilized amorphous calcium magnesium phosphate particle compositions | |
| Jabin et al. | Novel approaches in hard tissue remineralization: an overview | |
| RU2426690C2 (en) | Biologically active nanoparticles of carbonate-substituted hydroxyapatite, method of their production and compositions that include them | |
| US20250122088A1 (en) | Amorphous calcium magnesium fluoride phosphate particles | |
| JPH01163127A (en) | Composition for healing hyperesthesia | |
| EP3888623A1 (en) | Oral care system | |
| Uppala | A review of the literature on non-fluoridated remineralizing agents for dental caries | |
| Ibrahim et al. | Chapter Six: Remineralizing Response of in Vitro Carious Enamel to on-demand Calcium and Phosphate-ion Releasing Dental Sealants with Antimicrobial Properties |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |